id	sid	tid	token	lemma	pos
aiua-12856	1	1	stesura	stesura	PROPN
aiua-12856	1	2	seveso	seveso	PROPN
aiua-12856	1	3	archivio	archivio	PROPN
aiua-12856	1	4	italiano	italiano	X
aiua-12856	1	5	di	di	X
aiua-12856	1	6	urologia	urologia	PROPN
aiua-12856	1	7	e	e	PROPN
aiua-12856	1	8	andrologia	andrologia	NOUN
aiua-12856	1	9	2024	2024	NUM
aiua-12856	1	10	;	;	PUNCT
aiua-12856	1	11	96(3):12856	96(3):12856	NUM
aiua-12856	1	12	1	1	NUM
aiua-12856	1	13	original	original	ADJ
aiua-12856	1	14	paper	paper	NOUN
aiua-12856	1	15	sive	sive	NOUN
aiua-12856	1	16	,	,	PUNCT
aiua-12856	1	17	and	and	CCONJ
aiua-12856	1	18	there	there	PRON
aiua-12856	1	19	is	be	VERB
aiua-12856	1	20	a	a	DET
aiua-12856	1	21	lack	lack	NOUN
aiua-12856	1	22	of	of	ADP
aiua-12856	1	23	well	well	ADV
aiua-12856	1	24	-	-	PUNCT
aiua-12856	1	25	defined	define	VERB
aiua-12856	1	26	strategies	strategy	NOUN
aiua-12856	1	27	for	for	ADP
aiua-12856	1	28	patients	patient	NOUN
aiua-12856	1	29	whose	whose	DET
aiua-12856	1	30	metastatic	metastatic	ADJ
aiua-12856	1	31	penile	penile	ADJ
aiua-12856	1	32	carcinoma	carcinoma	NOUN
aiua-12856	1	33	progresses	progress	NOUN
aiua-12856	1	34	or	or	CCONJ
aiua-12856	1	35	recurs	recur	NOUN
aiua-12856	1	36	after	after	ADP
aiua-12856	1	37	front	front	ADJ
aiua-12856	1	38	-	-	PUNCT
aiua-12856	1	39	line	line	NOUN
aiua-12856	1	40	cisplatin	cisplatin	NOUN
aiua-12856	1	41	-	-	PUNCT
aiua-12856	1	42	based	base	VERB
aiua-12856	1	43	chemotherapy	chemotherapy	NOUN
aiua-12856	1	44	(	(	PUNCT
aiua-12856	1	45	4	4	NUM
aiua-12856	1	46	)	)	PUNCT
aiua-12856	1	47	.	.	PUNCT
aiua-12856	2	1	the	the	DET
aiua-12856	2	2	ability	ability	NOUN
aiua-12856	2	3	of	of	ADP
aiua-12856	2	4	tumor	tumor	NOUN
aiua-12856	2	5	cells	cell	NOUN
aiua-12856	2	6	to	to	PART
aiua-12856	2	7	evade	evade	VERB
aiua-12856	2	8	the	the	DET
aiua-12856	2	9	immune	immune	ADJ
aiua-12856	2	10	system	system	NOUN
aiua-12856	2	11	is	be	AUX
aiua-12856	2	12	one	one	NUM
aiua-12856	2	13	of	of	ADP
aiua-12856	2	14	the	the	DET
aiua-12856	2	15	many	many	ADJ
aiua-12856	2	16	characteristics	characteristic	NOUN
aiua-12856	2	17	of	of	ADP
aiua-12856	2	18	tumor	tumor	NOUN
aiua-12856	2	19	cells	cell	NOUN
aiua-12856	2	20	recognized	recognize	VERB
aiua-12856	2	21	as	as	ADP
aiua-12856	2	22	a	a	DET
aiua-12856	2	23	hallmark	hallmark	NOUN
aiua-12856	2	24	of	of	ADP
aiua-12856	2	25	cancer	cancer	NOUN
aiua-12856	2	26	(	(	PUNCT
aiua-12856	2	27	5	5	NUM
aiua-12856	2	28	)	)	PUNCT
aiua-12856	2	29	.	.	PUNCT
aiua-12856	3	1	the	the	DET
aiua-12856	3	2	programmed	program	VERB
aiua-12856	3	3	cell	cell	NOUN
aiua-12856	3	4	death	death	NOUN
aiua-12856	3	5	1	1	NUM
aiua-12856	3	6	and	and	CCONJ
aiua-12856	3	7	its	its	PRON
aiua-12856	3	8	ligand	ligand	NOUN
aiua-12856	3	9	(	(	PUNCT
aiua-12856	3	10	pd-1	pd-1	NOUN
aiua-12856	3	11	/	/	SYM
aiua-12856	3	12	pd	pd	NOUN
aiua-12856	3	13	-	-	PUNCT
aiua-12856	3	14	l1	l1	NOUN
aiua-12856	3	15	)	)	PUNCT
aiua-12856	3	16	pathway	pathway	NOUN
aiua-12856	3	17	is	be	AUX
aiua-12856	3	18	one	one	NUM
aiua-12856	3	19	of	of	ADP
aiua-12856	3	20	the	the	DET
aiua-12856	3	21	primary	primary	ADJ
aiua-12856	3	22	immune	immune	ADJ
aiua-12856	3	23	checkpoint	checkpoint	NOUN
aiua-12856	3	24	targets	target	NOUN
aiua-12856	3	25	that	that	PRON
aiua-12856	3	26	has	have	AUX
aiua-12856	3	27	been	be	AUX
aiua-12856	3	28	extensively	extensively	ADV
aiua-12856	3	29	studied	study	VERB
aiua-12856	3	30	in	in	ADP
aiua-12856	3	31	clinical	clinical	ADJ
aiua-12856	3	32	research	research	NOUN
aiua-12856	3	33	in	in	ADP
aiua-12856	3	34	recent	recent	ADJ
aiua-12856	3	35	years	year	NOUN
aiua-12856	3	36	(	(	PUNCT
aiua-12856	3	37	6	6	NUM
aiua-12856	3	38	)	)	PUNCT
aiua-12856	3	39	.	.	PUNCT
aiua-12856	4	1	pd	pd	PROPN
aiua-12856	4	2	-	-	PROPN
aiua-12856	4	3	l1	l1	PROPN
aiua-12856	4	4	acts	act	VERB
aiua-12856	4	5	as	as	ADP
aiua-12856	4	6	a	a	DET
aiua-12856	4	7	co	co	ADJ
aiua-12856	4	8	-	-	ADJ
aiua-12856	4	9	stimulatory	stimulatory	ADJ
aiua-12856	4	10	ligand	ligand	NOUN
aiua-12856	4	11	,	,	PUNCT
aiua-12856	4	12	which	which	PRON
aiua-12856	4	13	,	,	PUNCT
aiua-12856	4	14	upon	upon	SCONJ
aiua-12856	4	15	binding	bind	VERB
aiua-12856	4	16	with	with	ADP
aiua-12856	4	17	its	its	PRON
aiua-12856	4	18	receptor	receptor	NOUN
aiua-12856	4	19	pd-1	pd-1	ADP
aiua-12856	4	20	,	,	PUNCT
aiua-12856	4	21	functions	function	NOUN
aiua-12856	4	22	as	as	ADP
aiua-12856	4	23	a	a	DET
aiua-12856	4	24	negative	negative	ADJ
aiua-12856	4	25	regulator	regulator	NOUN
aiua-12856	4	26	of	of	ADP
aiua-12856	4	27	t	t	PROPN
aiua-12856	4	28	-	-	PUNCT
aiua-12856	4	29	cell	cell	NOUN
aiua-12856	4	30	-	-	PUNCT
aiua-12856	4	31	mediated	mediate	VERB
aiua-12856	4	32	antitumor	antitumor	NOUN
aiua-12856	4	33	immunity	immunity	NOUN
aiua-12856	4	34	(	(	PUNCT
aiua-12856	4	35	7	7	NUM
aiua-12856	4	36	)	)	PUNCT
aiua-12856	4	37	.	.	PUNCT
aiua-12856	5	1	although	although	SCONJ
aiua-12856	5	2	pd	pd	PROPN
aiua-12856	5	3	-	-	PUNCT
aiua-12856	5	4	l1	l1	PROPN
aiua-12856	5	5	expression	expression	NOUN
aiua-12856	5	6	is	be	AUX
aiua-12856	5	7	typically	typically	ADV
aiua-12856	5	8	induced	induce	VERB
aiua-12856	5	9	in	in	ADP
aiua-12856	5	10	cells	cell	NOUN
aiua-12856	5	11	of	of	ADP
aiua-12856	5	12	the	the	DET
aiua-12856	5	13	macrophage	macrophage	ADJ
aiua-12856	5	14	lineage	lineage	NOUN
aiua-12856	5	15	and	and	CCONJ
aiua-12856	5	16	t	t	NOUN
aiua-12856	5	17	cells	cell	NOUN
aiua-12856	5	18	,	,	PUNCT
aiua-12856	5	19	abnormal	abnormal	ADJ
aiua-12856	5	20	pd	pd	PROPN
aiua-12856	5	21	-	-	PUNCT
aiua-12856	5	22	l1	l1	PROPN
aiua-12856	5	23	expression	expression	NOUN
aiua-12856	5	24	has	have	AUX
aiua-12856	5	25	been	be	AUX
aiua-12856	5	26	detected	detect	VERB
aiua-12856	5	27	in	in	ADP
aiua-12856	5	28	various	various	ADJ
aiua-12856	5	29	types	type	NOUN
aiua-12856	5	30	of	of	ADP
aiua-12856	5	31	cancer	cancer	NOUN
aiua-12856	5	32	.	.	PUNCT
aiua-12856	6	1	this	this	PRON
aiua-12856	6	2	has	have	AUX
aiua-12856	6	3	led	lead	VERB
aiua-12856	6	4	to	to	ADP
aiua-12856	6	5	the	the	DET
aiua-12856	6	6	hypothesis	hypothesis	NOUN
aiua-12856	6	7	that	that	PRON
aiua-12856	6	8	pd	pd	PROPN
aiua-12856	6	9	-	-	PUNCT
aiua-12856	6	10	l1	l1	PROPN
aiua-12856	6	11	expression	expression	NOUN
aiua-12856	6	12	in	in	ADP
aiua-12856	6	13	either	either	CCONJ
aiua-12856	6	14	tumor	tumor	NOUN
aiua-12856	6	15	cells	cell	NOUN
aiua-12856	6	16	or	or	CCONJ
aiua-12856	6	17	tumor	tumor	NOUN
aiua-12856	6	18	-	-	PUNCT
aiua-12856	6	19	infiltrating	infiltrating	ADJ
aiua-12856	6	20	immune	immune	ADJ
aiua-12856	6	21	cells	cell	NOUN
aiua-12856	6	22	(	(	PUNCT
aiua-12856	6	23	tiics	tiic	NOUN
aiua-12856	6	24	)	)	PUNCT
aiua-12856	6	25	might	might	AUX
aiua-12856	6	26	facilitate	facilitate	VERB
aiua-12856	6	27	tumor	tumor	NOUN
aiua-12856	6	28	progression	progression	NOUN
aiua-12856	6	29	by	by	ADP
aiua-12856	6	30	inhibiting	inhibit	VERB
aiua-12856	6	31	the	the	DET
aiua-12856	6	32	antitumor	antitumor	PROPN
aiua-12856	6	33	immune	immune	ADJ
aiua-12856	6	34	response	response	NOUN
aiua-12856	6	35	(	(	PUNCT
aiua-12856	6	36	7	7	NUM
aiua-12856	6	37	)	)	PUNCT
aiua-12856	6	38	.	.	PUNCT
aiua-12856	7	1	currently	currently	ADV
aiua-12856	7	2	,	,	PUNCT
aiua-12856	7	3	several	several	ADJ
aiua-12856	7	4	clinical	clinical	ADJ
aiua-12856	7	5	studies	study	NOUN
aiua-12856	7	6	evaluating	evaluate	VERB
aiua-12856	7	7	pd-1	pd-1	ADP
aiua-12856	7	8	/	/	SYM
aiua-12856	7	9	pd	pd	ADJ
aiua-12856	7	10	-	-	PUNCT
aiua-12856	7	11	l1	l1	PROPN
aiua-12856	7	12	inhibitors	inhibitor	NOUN
aiua-12856	7	13	have	have	AUX
aiua-12856	7	14	been	be	AUX
aiua-12856	7	15	conducted	conduct	VERB
aiua-12856	7	16	in	in	ADP
aiua-12856	7	17	several	several	ADJ
aiua-12856	7	18	different	different	ADJ
aiua-12856	7	19	tumor	tumor	NOUN
aiua-12856	7	20	types	type	NOUN
aiua-12856	7	21	including	include	VERB
aiua-12856	7	22	melanoma	melanoma	NOUN
aiua-12856	7	23	,	,	PUNCT
aiua-12856	7	24	breast	breast	NOUN
aiua-12856	7	25	cancer	cancer	NOUN
aiua-12856	7	26	,	,	PUNCT
aiua-12856	7	27	non	non	ADJ
aiua-12856	7	28	-	-	ADJ
aiua-12856	7	29	small	small	ADJ
aiua-12856	7	30	-	-	PUNCT
aiua-12856	7	31	cell	cell	NOUN
aiua-12856	7	32	lung	lung	NOUN
aiua-12856	7	33	cancer	cancer	NOUN
aiua-12856	7	34	,	,	PUNCT
aiua-12856	7	35	and	and	CCONJ
aiua-12856	7	36	head	head	NOUN
aiua-12856	7	37	and	and	CCONJ
aiua-12856	7	38	neck	neck	NOUN
aiua-12856	7	39	cancer	cancer	NOUN
aiua-12856	7	40	.	.	PUNCT
aiua-12856	8	1	pd	pd	PROPN
aiua-12856	8	2	-	-	PUNCT
aiua-12856	8	3	l1	l1	PROPN
aiua-12856	8	4	expression	expression	NOUN
aiua-12856	8	5	has	have	AUX
aiua-12856	8	6	also	also	ADV
aiua-12856	8	7	been	be	AUX
aiua-12856	8	8	extensively	extensively	ADV
aiua-12856	8	9	studied	study	VERB
aiua-12856	8	10	in	in	ADP
aiua-12856	8	11	a	a	DET
aiua-12856	8	12	number	number	NOUN
aiua-12856	8	13	of	of	ADP
aiua-12856	8	14	urological	urological	ADJ
aiua-12856	8	15	malignancies	malignancy	NOUN
aiua-12856	8	16	such	such	ADJ
aiua-12856	8	17	as	as	ADP
aiua-12856	8	18	bladder	bladder	NOUN
aiua-12856	8	19	,	,	PUNCT
aiua-12856	8	20	kidney	kidney	NOUN
aiua-12856	8	21	,	,	PUNCT
aiua-12856	8	22	and	and	CCONJ
aiua-12856	8	23	prostate	prostate	NOUN
aiua-12856	8	24	cancer	cancer	NOUN
aiua-12856	8	25	.	.	PUNCT
aiua-12856	9	1	however	however	ADV
aiua-12856	9	2	,	,	PUNCT
aiua-12856	9	3	there	there	PRON
aiua-12856	9	4	have	have	AUX
aiua-12856	9	5	been	be	AUX
aiua-12856	9	6	relatively	relatively	ADV
aiua-12856	9	7	few	few	ADJ
aiua-12856	9	8	studies	study	NOUN
aiua-12856	9	9	on	on	ADP
aiua-12856	9	10	pd	pd	PROPN
aiua-12856	9	11	-	-	PUNCT
aiua-12856	9	12	l1	l1	PROPN
aiua-12856	9	13	expression	expression	NOUN
aiua-12856	9	14	in	in	ADP
aiua-12856	9	15	penile	penile	ADJ
aiua-12856	9	16	squamous	squamous	ADJ
aiua-12856	9	17	cell	cell	NOUN
aiua-12856	9	18	carcinoma	carcinoma	NOUN
aiua-12856	9	19	(	(	PUNCT
aiua-12856	9	20	8	8	NUM
aiua-12856	9	21	-	-	SYM
aiua-12856	9	22	10	10	NUM
aiua-12856	9	23	)	)	PUNCT
aiua-12856	9	24	.	.	PUNCT
aiua-12856	10	1	given	give	VERB
aiua-12856	10	2	the	the	DET
aiua-12856	10	3	aforementioned	aforementioned	ADJ
aiua-12856	10	4	difficulty	difficulty	NOUN
aiua-12856	10	5	in	in	ADP
aiua-12856	10	6	treating	treat	VERB
aiua-12856	10	7	recurrent	recurrent	ADJ
aiua-12856	10	8	and/or	and/or	CCONJ
aiua-12856	10	9	metastatic	metastatic	ADJ
aiua-12856	10	10	penile	penile	NOUN
aiua-12856	10	11	sqcc	sqcc	NOUN
aiua-12856	10	12	,	,	PUNCT
aiua-12856	10	13	the	the	DET
aiua-12856	10	14	targeting	targeting	NOUN
aiua-12856	10	15	of	of	ADP
aiua-12856	10	16	pd	pd	PROPN
aiua-12856	10	17	-	-	PROPN
aiua-12856	10	18	l1	l1	PROPN
aiua-12856	10	19	may	may	AUX
aiua-12856	10	20	offer	offer	VERB
aiua-12856	10	21	a	a	DET
aiua-12856	10	22	novel	novel	ADJ
aiua-12856	10	23	therapeutic	therapeutic	ADJ
aiua-12856	10	24	avenue	avenue	NOUN
aiua-12856	10	25	for	for	ADP
aiua-12856	10	26	those	those	DET
aiua-12856	10	27	patients	patient	NOUN
aiua-12856	10	28	who	who	PRON
aiua-12856	10	29	exhibit	exhibit	VERB
aiua-12856	10	30	pd	pd	PROPN
aiua-12856	10	31	-	-	PROPN
aiua-12856	10	32	l1	l1	PROPN
aiua-12856	10	33	expression	expression	NOUN
aiua-12856	10	34	upon	upon	SCONJ
aiua-12856	10	35	recurrence	recurrence	NOUN
aiua-12856	10	36	or	or	CCONJ
aiua-12856	10	37	progression	progression	NOUN
aiua-12856	10	38	after	after	ADP
aiua-12856	10	39	first	first	ADJ
aiua-12856	10	40	-	-	PUNCT
aiua-12856	10	41	line	line	NOUN
aiua-12856	10	42	chemotherapy	chemotherapy	NOUN
aiua-12856	10	43	.	.	PUNCT
aiua-12856	11	1	the	the	DET
aiua-12856	11	2	aim	aim	NOUN
aiua-12856	11	3	of	of	ADP
aiua-12856	11	4	our	our	PRON
aiua-12856	11	5	study	study	NOUN
aiua-12856	11	6	is	be	AUX
aiua-12856	11	7	to	to	PART
aiua-12856	11	8	investigate	investigate	VERB
aiua-12856	11	9	the	the	DET
aiua-12856	11	10	association	association	NOUN
aiua-12856	11	11	between	between	ADP
aiua-12856	11	12	pd	pd	PROPN
aiua-12856	11	13	-	-	PROPN
aiua-12856	11	14	l1	l1	PROPN
aiua-12856	11	15	immunoexpression	immunoexpression	NOUN
aiua-12856	11	16	as	as	ADP
aiua-12856	11	17	a	a	DET
aiua-12856	11	18	combined	combine	VERB
aiua-12856	11	19	positive	positive	ADJ
aiua-12856	11	20	score	score	NOUN
aiua-12856	11	21	and	and	CCONJ
aiua-12856	11	22	clinical	clinical	ADJ
aiua-12856	11	23	outcomes	outcome	NOUN
aiua-12856	11	24	in	in	ADP
aiua-12856	11	25	penile	penile	ADJ
aiua-12856	11	26	squamous	squamous	ADJ
aiua-12856	11	27	cell	cell	NOUN
aiua-12856	11	28	carcinoma	carcinoma	NOUN
aiua-12856	11	29	.	.	PUNCT
aiua-12856	12	1	methods	method	NOUN
aiua-12856	12	2	patients	patient	NOUN
aiua-12856	12	3	and	and	CCONJ
aiua-12856	12	4	samples	sample	NOUN
aiua-12856	12	5	we	we	PRON
aiua-12856	12	6	retrospectively	retrospectively	ADV
aiua-12856	12	7	reviewed	review	VERB
aiua-12856	12	8	all	all	DET
aiua-12856	12	9	penile	penile	ADJ
aiua-12856	12	10	sqcc	sqcc	NOUN
aiua-12856	12	11	cases	case	NOUN
aiua-12856	12	12	treated	treat	VERB
aiua-12856	12	13	in	in	ADP
aiua-12856	12	14	our	our	PRON
aiua-12856	12	15	institution	institution	NOUN
aiua-12856	12	16	between	between	ADP
aiua-12856	12	17	2018	2018	NUM
aiua-12856	12	18	and	and	CCONJ
aiua-12856	12	19	2023	2023	NUM
aiua-12856	12	20	.	.	PUNCT
aiua-12856	13	1	tumors	tumor	NOUN
aiua-12856	13	2	were	be	AUX
aiua-12856	13	3	classified	classify	VERB
aiua-12856	13	4	according	accord	VERB
aiua-12856	13	5	to	to	ADP
aiua-12856	13	6	the	the	DET
aiua-12856	13	7	5th	5th	ADJ
aiua-12856	13	8	edition	edition	NOUN
aiua-12856	13	9	of	of	ADP
aiua-12856	13	10	the	the	DET
aiua-12856	13	11	world	world	PROPN
aiua-12856	13	12	health	health	PROPN
aiua-12856	13	13	organization	organization	NOUN
aiua-12856	13	14	urinary	urinary	ADJ
aiua-12856	13	15	and	and	CCONJ
aiua-12856	13	16	male	male	ADJ
aiua-12856	13	17	genital	genital	ADJ
aiua-12856	13	18	tumors	tumor	NOUN
aiua-12856	13	19	2004	2004	NUM
aiua-12856	13	20	tnm	tnm	NUM
aiua-12856	13	21	classification	classification	NOUN
aiua-12856	13	22	.	.	PUNCT
aiua-12856	14	1	exclusion	exclusion	NOUN
aiua-12856	14	2	factors	factor	NOUN
aiua-12856	14	3	included	include	VERB
aiua-12856	14	4	a	a	DET
aiua-12856	14	5	non	non	ADJ
aiua-12856	14	6	-	-	ADJ
aiua-12856	14	7	squamous	squamous	ADJ
aiua-12856	14	8	cell	cell	NOUN
aiua-12856	14	9	carcinoma	carcinoma	NOUN
aiua-12856	14	10	diagnosis	diagnosis	NOUN
aiua-12856	14	11	and	and	CCONJ
aiua-12856	14	12	cases	case	NOUN
aiua-12856	14	13	without	without	ADP
aiua-12856	14	14	available	available	ADJ
aiua-12856	14	15	purpose	purpose	NOUN
aiua-12856	14	16	:	:	PUNCT
aiua-12856	14	17	our	our	PRON
aiua-12856	14	18	objective	objective	NOUN
aiua-12856	14	19	was	be	AUX
aiua-12856	14	20	to	to	PART
aiua-12856	14	21	investigate	investigate	VERB
aiua-12856	14	22	the	the	DET
aiua-12856	14	23	association	association	NOUN
aiua-12856	14	24	between	between	ADP
aiua-12856	14	25	programmed	program	VERB
aiua-12856	14	26	death	death	NOUN
aiua-12856	14	27	-	-	PUNCT
aiua-12856	14	28	ligand	ligand	NOUN
aiua-12856	14	29	(	(	PUNCT
aiua-12856	14	30	pd	pd	NOUN
aiua-12856	14	31	-	-	PUNCT
aiua-12856	14	32	l1	l1	NOUN
aiua-12856	14	33	)	)	PUNCT
aiua-12856	14	34	immunoexpression	immunoexpression	NOUN
aiua-12856	14	35	measured	measure	VERB
aiua-12856	14	36	as	as	ADP
aiua-12856	14	37	a	a	DET
aiua-12856	14	38	combined	combine	VERB
aiua-12856	14	39	positive	positive	ADJ
aiua-12856	14	40	score	score	NOUN
aiua-12856	14	41	and	and	CCONJ
aiua-12856	14	42	clinical	clinical	ADJ
aiua-12856	14	43	outcomes	outcome	NOUN
aiua-12856	14	44	in	in	ADP
aiua-12856	14	45	penile	penile	ADJ
aiua-12856	14	46	sqcc	sqcc	NOUN
aiua-12856	14	47	.	.	PUNCT
aiua-12856	15	1	materials	material	NOUN
aiua-12856	15	2	and	and	CCONJ
aiua-12856	15	3	methods	method	NOUN
aiua-12856	15	4	:	:	PUNCT
aiua-12856	15	5	we	we	PRON
aiua-12856	15	6	retrospectively	retrospectively	ADV
aiua-12856	15	7	reviewed	review	VERB
aiua-12856	15	8	all	all	DET
aiua-12856	15	9	penile	penile	ADJ
aiua-12856	15	10	sqcc	sqcc	NOUN
aiua-12856	15	11	cases	case	NOUN
aiua-12856	15	12	diagnosed	diagnose	VERB
aiua-12856	15	13	in	in	ADP
aiua-12856	15	14	our	our	PRON
aiua-12856	15	15	institution	institution	NOUN
aiua-12856	15	16	between	between	ADP
aiua-12856	15	17	2018	2018	NUM
aiua-12856	15	18	and	and	CCONJ
aiua-12856	15	19	2023	2023	NUM
aiua-12856	15	20	.	.	PUNCT
aiua-12856	16	1	pd	pd	PROPN
aiua-12856	16	2	-	-	PUNCT
aiua-12856	16	3	l1	l1	PROPN
aiua-12856	16	4	immunohistochemistry	immunohistochemistry	NOUN
aiua-12856	16	5	was	be	AUX
aiua-12856	16	6	performed	perform	VERB
aiua-12856	16	7	as	as	ADP
aiua-12856	16	8	a	a	DET
aiua-12856	16	9	qualitative	qualitative	NOUN
aiua-12856	16	10	assay	assay	NOUN
aiua-12856	16	11	.	.	PUNCT
aiua-12856	17	1	immunoexpression	immunoexpression	NOUN
aiua-12856	17	2	in	in	ADP
aiua-12856	17	3	both	both	DET
aiua-12856	17	4	tumor	tumor	NOUN
aiua-12856	17	5	and	and	CCONJ
aiua-12856	17	6	immune	immune	ADJ
aiua-12856	17	7	cells	cell	NOUN
aiua-12856	17	8	equal	equal	ADJ
aiua-12856	17	9	or	or	CCONJ
aiua-12856	17	10	superior	superior	ADJ
aiua-12856	17	11	to	to	ADP
aiua-12856	17	12	1	1	NUM
aiua-12856	17	13	was	be	AUX
aiua-12856	17	14	considered	consider	VERB
aiua-12856	17	15	positive	positive	ADJ
aiua-12856	17	16	.	.	PUNCT
aiua-12856	18	1	results	result	NOUN
aiua-12856	18	2	:	:	PUNCT
aiua-12856	18	3	a	a	DET
aiua-12856	18	4	total	total	NOUN
aiua-12856	18	5	of	of	ADP
aiua-12856	18	6	34	34	NUM
aiua-12856	18	7	patients	patient	NOUN
aiua-12856	18	8	with	with	ADP
aiua-12856	18	9	conventional	conventional	ADJ
aiua-12856	18	10	penile	penile	ADJ
aiua-12856	18	11	sqcc	sqcc	NOUN
aiua-12856	18	12	were	be	AUX
aiua-12856	18	13	included	include	VERB
aiua-12856	18	14	.	.	PUNCT
aiua-12856	19	1	eleven	eleven	NUM
aiua-12856	19	2	cases	case	NOUN
aiua-12856	19	3	were	be	AUX
aiua-12856	19	4	hpv	hpv	NOUN
aiua-12856	19	5	-	-	PUNCT
aiua-12856	19	6	associated	associate	VERB
aiua-12856	19	7	(	(	PUNCT
aiua-12856	19	8	32.4	32.4	NUM
aiua-12856	19	9	%	%	NOUN
aiua-12856	19	10	)	)	PUNCT
aiua-12856	19	11	.	.	PUNCT
aiua-12856	20	1	twelve	twelve	NUM
aiua-12856	20	2	cases	case	NOUN
aiua-12856	20	3	were	be	AUX
aiua-12856	20	4	pd	pd	ADJ
aiua-12856	20	5	-	-	PROPN
aiua-12856	20	6	l1	l1	PROPN
aiua-12856	20	7	cps	cps	PROPN
aiua-12856	20	8	<	<	X
aiua-12856	20	9	1	1	NUM
aiua-12856	20	10	and	and	CCONJ
aiua-12856	20	11	twenty	twenty	NUM
aiua-12856	20	12	-	-	PUNCT
aiua-12856	20	13	two	two	NUM
aiua-12856	20	14	were	be	AUX
aiua-12856	20	15	pd	pd	PROPN
aiua-12856	20	16	-	-	PROPN
aiua-12856	20	17	l1	l1	PROPN
aiua-12856	20	18	cps	cps	PROPN
aiua-12856	20	19	≥	≥	PROPN
aiua-12856	20	20	1	1	NUM
aiua-12856	20	21	.	.	X
aiua-12856	20	22	nine	nine	NUM
aiua-12856	20	23	cases	case	NOUN
aiua-12856	20	24	(	(	PUNCT
aiua-12856	20	25	32.4	32.4	NUM
aiua-12856	20	26	%	%	NOUN
aiua-12856	20	27	)	)	PUNCT
aiua-12856	20	28	were	be	AUX
aiua-12856	20	29	pd	pd	PROPN
aiua-12856	20	30	-	-	PROPN
aiua-12856	20	31	l1	l1	PROPN
aiua-12856	20	32	cps	cps	PROPN
aiua-12856	20	33	≥	≥	PROPN
aiua-12856	20	34	1	1	NUM
aiua-12856	20	35	and	and	CCONJ
aiua-12856	20	36	p16	p16	NOUN
aiua-12856	20	37	positive	positive	ADJ
aiua-12856	20	38	,	,	PUNCT
aiua-12856	20	39	but	but	CCONJ
aiua-12856	20	40	this	this	PRON
aiua-12856	20	41	did	do	AUX
aiua-12856	20	42	not	not	PART
aiua-12856	20	43	translate	translate	VERB
aiua-12856	20	44	in	in	ADP
aiua-12856	20	45	worse	bad	ADJ
aiua-12856	20	46	clinicopathological	clinicopathological	ADJ
aiua-12856	20	47	features	feature	NOUN
aiua-12856	20	48	.	.	PUNCT
aiua-12856	21	1	larger	large	ADJ
aiua-12856	21	2	tumors	tumor	NOUN
aiua-12856	21	3	(	(	PUNCT
aiua-12856	21	4	3.0	3.0	NUM
aiua-12856	21	5	cm	cm	NOUN
aiua-12856	21	6	in	in	ADP
aiua-12856	21	7	pd	pd	PROPN
aiua-12856	21	8	-	-	PROPN
aiua-12856	21	9	l1	l1	PROPN
aiua-12856	21	10	cps	cps	PROPN
aiua-12856	21	11	≥	≥	PROPN
aiua-12856	21	12	1	1	NUM
aiua-12856	21	13	vs	vs	ADP
aiua-12856	21	14	2.5	2.5	NUM
aiua-12856	21	15	cm	cm	NOUN
aiua-12856	21	16	in	in	ADP
aiua-12856	21	17	pd	pd	PROPN
aiua-12856	21	18	-	-	PROPN
aiua-12856	21	19	l1	l1	PROPN
aiua-12856	21	20	cps	cps	PROPN
aiua-12856	21	21	<	<	X
aiua-12856	21	22	1	1	NUM
aiua-12856	21	23	;	;	PUNCT
aiua-12856	21	24	p	p	NOUN
aiua-12856	21	25	=	=	NOUN
aiua-12856	21	26	0.662	0.662	NUM
aiua-12856	21	27	)	)	PUNCT
aiua-12856	21	28	,	,	PUNCT
aiua-12856	21	29	vascular	vascular	ADJ
aiua-12856	21	30	invasion	invasion	NOUN
aiua-12856	21	31	(	(	PUNCT
aiua-12856	21	32	36.4	36.4	NUM
aiua-12856	21	33	%	%	NOUN
aiua-12856	21	34	in	in	ADP
aiua-12856	21	35	pd	pd	PROPN
aiua-12856	21	36	-	-	PROPN
aiua-12856	21	37	l1	l1	PROPN
aiua-12856	21	38	cps	cps	PROPN
aiua-12856	21	39	≥	≥	PROPN
aiua-12856	21	40	1	1	NUM
aiua-12856	21	41	vs.	vs.	ADP
aiua-12856	21	42	25.0	25.0	NUM
aiua-12856	21	43	%	%	NOUN
aiua-12856	21	44	in	in	ADP
aiua-12856	21	45	pd	pd	PROPN
aiua-12856	21	46	-	-	PROPN
aiua-12856	21	47	l1	l1	PROPN
aiua-12856	21	48	cps	cps	PROPN
aiua-12856	21	49	<	<	X
aiua-12856	21	50	1	1	NUM
aiua-12856	21	51	;	;	PUNCT
aiua-12856	21	52	p	p	NOUN
aiua-12856	21	53	=	=	NOUN
aiua-12856	21	54	0.705	0.705	NUM
aiua-12856	21	55	)	)	PUNCT
aiua-12856	21	56	and	and	CCONJ
aiua-12856	21	57	perineural	perineural	ADJ
aiua-12856	21	58	invasion	invasion	NOUN
aiua-12856	21	59	(	(	PUNCT
aiua-12856	21	60	40.9	40.9	NUM
aiua-12856	21	61	%	%	NOUN
aiua-12856	21	62	in	in	ADP
aiua-12856	21	63	pd	pd	PROPN
aiua-12856	21	64	-	-	PROPN
aiua-12856	21	65	l1	l1	PROPN
aiua-12856	21	66	cps≥1	cps≥1	X
aiua-12856	21	67	vs.	vs.	ADP
aiua-12856	21	68	16.7	16.7	NUM
aiua-12856	21	69	%	%	NOUN
aiua-12856	21	70	in	in	ADP
aiua-12856	21	71	pd	pd	PROPN
aiua-12856	21	72	-	-	PROPN
aiua-12856	21	73	l1	l1	PROPN
aiua-12856	21	74	cps	cps	PROPN
aiua-12856	21	75	<	<	X
aiua-12856	21	76	1	1	NUM
aiua-12856	21	77	;	;	PUNCT
aiua-12856	21	78	p	p	NOUN
aiua-12856	21	79	=	=	NOUN
aiua-12856	21	80	0.252	0.252	NUM
aiua-12856	21	81	)	)	PUNCT
aiua-12856	21	82	were	be	AUX
aiua-12856	21	83	associated	associate	VERB
aiua-12856	21	84	with	with	ADP
aiua-12856	21	85	pd	pd	PROPN
aiua-12856	21	86	-	-	PROPN
aiua-12856	21	87	l1	l1	PROPN
aiua-12856	21	88	expression	expression	NOUN
aiua-12856	21	89	.	.	PUNCT
aiua-12856	22	1	among	among	ADP
aiua-12856	22	2	the	the	DET
aiua-12856	22	3	high	high	ADJ
aiua-12856	22	4	-	-	PUNCT
aiua-12856	22	5	risk	risk	NOUN
aiua-12856	22	6	features	feature	NOUN
aiua-12856	22	7	,	,	PUNCT
aiua-12856	22	8	only	only	ADV
aiua-12856	22	9	lymph	lymph	NOUN
aiua-12856	22	10	node	node	PROPN
aiua-12856	22	11	involvement	involvement	NOUN
aiua-12856	22	12	had	have	VERB
aiua-12856	22	13	statistical	statistical	ADJ
aiua-12856	22	14	significance	significance	NOUN
aiua-12856	22	15	,	,	PUNCT
aiua-12856	22	16	with	with	ADP
aiua-12856	22	17	14	14	NUM
aiua-12856	22	18	out	out	ADP
aiua-12856	22	19	of	of	ADP
aiua-12856	22	20	22	22	NUM
aiua-12856	22	21	pd	pd	PROPN
aiua-12856	22	22	-	-	PROPN
aiua-12856	22	23	l1	l1	PROPN
aiua-12856	22	24	cps	cps	PROPN
aiua-12856	22	25	≥	≥	PROPN
aiua-12856	22	26	1	1	NUM
aiua-12856	22	27	patients	patient	NOUN
aiua-12856	22	28	(	(	PUNCT
aiua-12856	22	29	63.6	63.6	NUM
aiua-12856	22	30	%	%	NOUN
aiua-12856	22	31	)	)	PUNCT
aiua-12856	22	32	having	have	VERB
aiua-12856	22	33	lymph	lymph	NOUN
aiua-12856	22	34	node	node	NOUN
aiua-12856	22	35	metastases	metastasis	NOUN
aiua-12856	22	36	when	when	SCONJ
aiua-12856	22	37	lymphadenectomy	lymphadenectomy	NOUN
aiua-12856	22	38	was	be	AUX
aiua-12856	22	39	performed	perform	VERB
aiua-12856	22	40	(	(	PUNCT
aiua-12856	22	41	p	p	X
aiua-12856	22	42	=	=	NOUN
aiua-12856	22	43	0.031	0.031	NUM
aiua-12856	22	44	)	)	PUNCT
aiua-12856	22	45	.	.	PUNCT
aiua-12856	23	1	with	with	ADP
aiua-12856	23	2	a	a	DET
aiua-12856	23	3	median	median	ADJ
aiua-12856	23	4	follow	follow	NOUN
aiua-12856	23	5	-	-	PUNCT
aiua-12856	23	6	up	up	NOUN
aiua-12856	23	7	of	of	ADP
aiua-12856	23	8	16	16	NUM
aiua-12856	23	9	months	month	NOUN
aiua-12856	23	10	(	(	PUNCT
aiua-12856	23	11	iqr	iqr	NOUN
aiua-12856	23	12	27.5	27.5	NUM
aiua-12856	23	13	)	)	PUNCT
aiua-12856	23	14	,	,	PUNCT
aiua-12856	23	15	pd	pd	PROPN
aiua-12856	23	16	-	-	PROPN
aiua-12856	23	17	l1	l1	PROPN
aiua-12856	23	18	cps	cps	PROPN
aiua-12856	23	19	≥	≥	PROPN
aiua-12856	23	20	1	1	NUM
aiua-12856	23	21	patients	patient	NOUN
aiua-12856	23	22	had	have	VERB
aiua-12856	23	23	worse	bad	ADJ
aiua-12856	23	24	overall	overall	ADJ
aiua-12856	23	25	survival	survival	NOUN
aiua-12856	23	26	(	(	PUNCT
aiua-12856	23	27	53.4	53.4	NUM
aiua-12856	23	28	months	month	NOUN
aiua-12856	23	29	vs	vs	ADP
aiua-12856	23	30	75.9	75.9	NUM
aiua-12856	23	31	months	month	NOUN
aiua-12856	23	32	)	)	PUNCT
aiua-12856	23	33	,	,	PUNCT
aiua-12856	23	34	but	but	CCONJ
aiua-12856	23	35	no	no	DET
aiua-12856	23	36	statistical	statistical	ADJ
aiua-12856	23	37	significance	significance	NOUN
aiua-12856	23	38	could	could	AUX
aiua-12856	23	39	be	be	AUX
aiua-12856	23	40	inferred	infer	VERB
aiua-12856	23	41	(	(	PUNCT
aiua-12856	23	42	p	p	X
aiua-12856	23	43	=	=	NOUN
aiua-12856	23	44	0.188	0.188	NUM
aiua-12856	23	45	)	)	PUNCT
aiua-12856	23	46	.	.	PUNCT
aiua-12856	24	1	conclusions	conclusion	NOUN
aiua-12856	24	2	:	:	PUNCT
aiua-12856	24	3	it	it	PRON
aiua-12856	24	4	is	be	AUX
aiua-12856	24	5	noteworthy	noteworthy	ADJ
aiua-12856	24	6	the	the	DET
aiua-12856	24	7	clinical	clinical	ADJ
aiua-12856	24	8	significance	significance	NOUN
aiua-12856	24	9	of	of	ADP
aiua-12856	24	10	lymph	lymph	NOUN
aiua-12856	24	11	node	node	NOUN
aiua-12856	24	12	involvement	involvement	NOUN
aiua-12856	24	13	in	in	ADP
aiua-12856	24	14	pd	pd	PROPN
aiua-12856	24	15	-	-	PROPN
aiua-12856	24	16	l1	l1	PROPN
aiua-12856	24	17	cps	cps	PROPN
aiua-12856	24	18	≥	≥	NUM
aiua-12856	24	19	1	1	NUM
aiua-12856	24	20	cases	case	NOUN
aiua-12856	24	21	and	and	CCONJ
aiua-12856	24	22	a	a	DET
aiua-12856	24	23	trend	trend	NOUN
aiua-12856	24	24	towards	towards	ADP
aiua-12856	24	25	worse	bad	ADJ
aiua-12856	24	26	overall	overall	ADJ
aiua-12856	24	27	survival	survival	NOUN
aiua-12856	24	28	in	in	ADP
aiua-12856	24	29	this	this	DET
aiua-12856	24	30	group	group	NOUN
aiua-12856	24	31	of	of	ADP
aiua-12856	24	32	patients	patient	NOUN
aiua-12856	24	33	.	.	PUNCT
aiua-12856	25	1	key	key	ADJ
aiua-12856	25	2	words	word	NOUN
aiua-12856	25	3	:	:	PUNCT
aiua-12856	25	4	pd	pd	NOUN
aiua-12856	25	5	-	-	PUNCT
aiua-12856	25	6	l1	l1	PROPN
aiua-12856	25	7	;	;	PUNCT
aiua-12856	25	8	penile	penile	NOUN
aiua-12856	25	9	carcinoma	carcinoma	NOUN
aiua-12856	25	10	;	;	PUNCT
aiua-12856	25	11	lymph	lymph	NOUN
aiua-12856	25	12	node	node	NOUN
aiua-12856	25	13	involvement	involvement	NOUN
aiua-12856	25	14	;	;	PUNCT
aiua-12856	25	15	prognostic	prognostic	ADJ
aiua-12856	25	16	biomarker	biomarker	NOUN
aiua-12856	25	17	.	.	PUNCT
aiua-12856	25	18	submitted	submit	VERB
aiua-12856	25	19	25	25	NUM
aiua-12856	25	20	july	july	PROPN
aiua-12856	25	21	2024	2024	NUM
aiua-12856	25	22	;	;	PUNCT
aiua-12856	25	23	accepted	accept	VERB
aiua-12856	25	24	2	2	NUM
aiua-12856	25	25	august	august	PROPN
aiua-12856	25	26	2024	2024	NUM
aiua-12856	25	27	introduction	introduction	NOUN
aiua-12856	25	28	penile	penile	NOUN
aiua-12856	25	29	cancer	cancer	NOUN
aiua-12856	25	30	(	(	PUNCT
aiua-12856	25	31	pc	pc	NOUN
aiua-12856	25	32	)	)	PUNCT
aiua-12856	25	33	is	be	AUX
aiua-12856	25	34	a	a	DET
aiua-12856	25	35	rare	rare	ADJ
aiua-12856	25	36	form	form	NOUN
aiua-12856	25	37	of	of	ADP
aiua-12856	25	38	cancer	cancer	NOUN
aiua-12856	25	39	in	in	ADP
aiua-12856	25	40	western	western	ADJ
aiua-12856	25	41	nations	nation	NOUN
aiua-12856	25	42	,	,	PUNCT
aiua-12856	25	43	with	with	ADP
aiua-12856	25	44	squamous	squamous	ADJ
aiua-12856	25	45	cell	cell	NOUN
aiua-12856	25	46	carcinoma	carcinoma	NOUN
aiua-12856	25	47	(	(	PUNCT
aiua-12856	25	48	sqcc	sqcc	NOUN
aiua-12856	25	49	)	)	PUNCT
aiua-12856	25	50	being	be	AUX
aiua-12856	25	51	the	the	DET
aiua-12856	25	52	most	most	ADV
aiua-12856	25	53	common	common	ADJ
aiua-12856	25	54	type	type	NOUN
aiua-12856	25	55	,	,	PUNCT
aiua-12856	25	56	accounting	account	VERB
aiua-12856	25	57	for	for	ADP
aiua-12856	25	58	around	around	ADV
aiua-12856	25	59	95	95	NUM
aiua-12856	25	60	%	%	NOUN
aiua-12856	25	61	of	of	ADP
aiua-12856	25	62	cases	case	NOUN
aiua-12856	25	63	(	(	PUNCT
aiua-12856	25	64	1	1	X
aiua-12856	25	65	)	)	PUNCT
aiua-12856	25	66	the	the	DET
aiua-12856	25	67	global	global	ADJ
aiua-12856	25	68	incidence	incidence	NOUN
aiua-12856	25	69	of	of	ADP
aiua-12856	25	70	pc	pc	NOUN
aiua-12856	25	71	varies	varie	NOUN
aiua-12856	25	72	due	due	ADJ
aiua-12856	25	73	to	to	ADP
aiua-12856	25	74	differences	difference	NOUN
aiua-12856	25	75	in	in	ADP
aiua-12856	25	76	socioeconomic	socioeconomic	ADJ
aiua-12856	25	77	and	and	CCONJ
aiua-12856	25	78	religious	religious	ADJ
aiua-12856	25	79	factors	factor	NOUN
aiua-12856	25	80	,	,	PUNCT
aiua-12856	25	81	representing	represent	VERB
aiua-12856	25	82	less	less	ADJ
aiua-12856	25	83	than	than	ADP
aiua-12856	25	84	1	1	NUM
aiua-12856	25	85	%	%	NOUN
aiua-12856	25	86	of	of	ADP
aiua-12856	25	87	all	all	DET
aiua-12856	25	88	malignancies	malignancy	NOUN
aiua-12856	25	89	in	in	ADP
aiua-12856	25	90	western	western	PROPN
aiua-12856	25	91	europe	europe	PROPN
aiua-12856	25	92	(	(	PUNCT
aiua-12856	25	93	2	2	NUM
aiua-12856	25	94	)	)	PUNCT
aiua-12856	25	95	.	.	PUNCT
aiua-12856	26	1	regions	region	NOUN
aiua-12856	26	2	with	with	ADP
aiua-12856	26	3	high	high	ADJ
aiua-12856	26	4	rates	rate	NOUN
aiua-12856	26	5	of	of	ADP
aiua-12856	26	6	human	human	ADJ
aiua-12856	26	7	papillomavirus	papillomavirus	NOUN
aiua-12856	26	8	(	(	PUNCT
aiua-12856	26	9	hpv	hpv	NOUN
aiua-12856	26	10	)	)	PUNCT
aiua-12856	26	11	infection	infection	NOUN
aiua-12856	26	12	are	be	AUX
aiua-12856	26	13	most	most	ADV
aiua-12856	26	14	affected	affect	VERB
aiua-12856	26	15	by	by	ADP
aiua-12856	26	16	penile	penile	ADJ
aiua-12856	26	17	cancer	cancer	NOUN
aiua-12856	26	18	,	,	PUNCT
aiua-12856	26	19	with	with	ADP
aiua-12856	26	20	approximately	approximately	ADV
aiua-12856	26	21	one	one	NUM
aiua-12856	26	22	third	third	ADJ
aiua-12856	26	23	to	to	ADP
aiua-12856	26	24	half	half	NOUN
aiua-12856	26	25	of	of	ADP
aiua-12856	26	26	cases	case	NOUN
aiua-12856	26	27	attributed	attribute	VERB
aiua-12856	26	28	to	to	ADP
aiua-12856	26	29	hpv	hpv	NOUN
aiua-12856	26	30	-	-	PUNCT
aiua-12856	26	31	related	relate	VERB
aiua-12856	26	32	causes	cause	NOUN
aiua-12856	26	33	(	(	PUNCT
aiua-12856	26	34	3	3	NUM
aiua-12856	26	35	)	)	PUNCT
aiua-12856	26	36	.	.	PUNCT
aiua-12856	27	1	the	the	DET
aiua-12856	27	2	management	management	NOUN
aiua-12856	27	3	of	of	ADP
aiua-12856	27	4	penile	penile	ADJ
aiua-12856	27	5	cancer	cancer	NOUN
aiua-12856	27	6	presents	present	VERB
aiua-12856	27	7	a	a	DET
aiua-12856	27	8	significant	significant	ADJ
aiua-12856	27	9	challenge	challenge	NOUN
aiua-12856	27	10	for	for	ADP
aiua-12856	27	11	clinicians	clinician	NOUN
aiua-12856	27	12	.	.	PUNCT
aiua-12856	28	1	this	this	DET
aiua-12856	28	2	malignancy	malignancy	NOUN
aiua-12856	28	3	is	be	AUX
aiua-12856	28	4	highly	highly	ADV
aiua-12856	28	5	aggresprogrammed	aggresprogramme	VERB
aiua-12856	28	6	death	death	NOUN
aiua-12856	28	7	-	-	PUNCT
aiua-12856	28	8	ligand	ligand	NOUN
aiua-12856	28	9	expression	expression	NOUN
aiua-12856	28	10	and	and	CCONJ
aiua-12856	28	11	lymph	lymph	NOUN
aiua-12856	28	12	node	node	ADJ
aiua-12856	28	13	involvement	involvement	NOUN
aiua-12856	28	14	in	in	ADP
aiua-12856	28	15	penile	penile	ADJ
aiua-12856	28	16	squamous	squamous	ADJ
aiua-12856	28	17	cell	cell	NOUN
aiua-12856	28	18	carcinoma	carcinoma	NOUN
aiua-12856	28	19	ines	ines	PROPN
aiua-12856	28	20	peyroteo	peyroteo	PROPN
aiua-12856	28	21	1	1	NUM
aiua-12856	28	22	,	,	PUNCT
aiua-12856	28	23	filipa	filipa	PROPN
aiua-12856	28	24	santos	santos	PROPN
aiua-12856	28	25	2	2	NUM
aiua-12856	28	26	,	,	PUNCT
aiua-12856	28	27	celso	celso	NOUN
aiua-12856	28	28	marialva	marialva	PROPN
aiua-12856	28	29	1	1	NUM
aiua-12856	28	30	,	,	PUNCT
aiua-12856	28	31	rodrigo	rodrigo	PROPN
aiua-12856	28	32	ramos	ramos	PROPN
aiua-12856	28	33	1	1	NUM
aiua-12856	28	34	1	1	NUM
aiua-12856	28	35	portuguese	portuguese	PROPN
aiua-12856	28	36	institute	institute	NOUN
aiua-12856	28	37	of	of	ADP
aiua-12856	28	38	oncology	oncology	NOUN
aiua-12856	28	39	in	in	ADP
aiua-12856	28	40	lisbon	lisbon	PROPN
aiua-12856	28	41	,	,	PUNCT
aiua-12856	28	42	urology	urology	NOUN
aiua-12856	28	43	,	,	PUNCT
aiua-12856	28	44	lisbon	lisbon	PROPN
aiua-12856	28	45	,	,	PUNCT
aiua-12856	28	46	portugal	portugal	PROPN
aiua-12856	28	47	.	.	PROPN
aiua-12856	28	48	2	2	NUM
aiua-12856	28	49	portuguese	portuguese	PROPN
aiua-12856	28	50	institute	institute	NOUN
aiua-12856	28	51	of	of	ADP
aiua-12856	28	52	oncology	oncology	NOUN
aiua-12856	28	53	in	in	ADP
aiua-12856	28	54	lisbon	lisbon	PROPN
aiua-12856	28	55	,	,	PUNCT
aiua-12856	28	56	pathology	pathology	NOUN
aiua-12856	28	57	,	,	PUNCT
aiua-12856	28	58	lisbon	lisbon	PROPN
aiua-12856	28	59	,	,	PUNCT
aiua-12856	28	60	portugal	portugal	PROPN
aiua-12856	28	61	.	.	PUNCT
aiua-12856	29	1	doi	doi	PROPN
aiua-12856	29	2	:	:	PUNCT
aiua-12856	29	3	10.4081	10.4081	NUM
aiua-12856	29	4	/	/	SYM
aiua-12856	29	5	aiua.2024.12856	aiua.2024.12856	NOUN
aiua-12856	29	6	summary	summary	NOUN
aiua-12856	29	7	archivio	archivio	NOUN
aiua-12856	29	8	italiano	italiano	X
aiua-12856	29	9	di	di	X
aiua-12856	29	10	urologia	urologia	PROPN
aiua-12856	29	11	e	e	PROPN
aiua-12856	29	12	andrologia	andrologia	NOUN
aiua-12856	29	13	2024	2024	NUM
aiua-12856	29	14	;	;	PUNCT
aiua-12856	29	15	96(3):12856	96(3):12856	NUM
aiua-12856	29	16	i.	i.	NOUN
aiua-12856	29	17	peyroteo	peyroteo	PROPN
aiua-12856	29	18	,	,	PUNCT
aiua-12856	29	19	f.	f.	PROPN
aiua-12856	29	20	santos	santos	PROPN
aiua-12856	29	21	,	,	PUNCT
aiua-12856	29	22	c.	c.	PROPN
aiua-12856	29	23	marialva	marialva	PROPN
aiua-12856	29	24	,	,	PUNCT
aiua-12856	29	25	r.	r.	PROPN
aiua-12856	29	26	ramos	ramos	PROPN
aiua-12856	29	27	2	2	NUM
aiua-12856	29	28	material	material	NOUN
aiua-12856	29	29	for	for	ADP
aiua-12856	29	30	additional	additional	ADJ
aiua-12856	29	31	immunohistochemistry	immunohistochemistry	NOUN
aiua-12856	29	32	studies	study	NOUN
aiua-12856	29	33	and	and	CCONJ
aiua-12856	29	34	without	without	ADP
aiua-12856	29	35	clinical	clinical	ADJ
aiua-12856	29	36	follow	follow	NOUN
aiua-12856	29	37	-	-	PUNCT
aiua-12856	29	38	up	up	NOUN
aiua-12856	29	39	.	.	PUNCT
aiua-12856	30	1	baseline	baseline	PROPN
aiua-12856	30	2	patient	patient	ADJ
aiua-12856	30	3	and	and	CCONJ
aiua-12856	30	4	disease	disease	NOUN
aiua-12856	30	5	characteristics	characteristic	NOUN
aiua-12856	30	6	were	be	AUX
aiua-12856	30	7	assessed	assess	VERB
aiua-12856	30	8	for	for	ADP
aiua-12856	30	9	the	the	DET
aiua-12856	30	10	selected	select	VERB
aiua-12856	30	11	patients	patient	NOUN
aiua-12856	30	12	.	.	PUNCT
aiua-12856	31	1	all	all	DET
aiua-12856	31	2	penile	penile	ADJ
aiua-12856	31	3	specimens	specimen	NOUN
aiua-12856	31	4	were	be	AUX
aiua-12856	31	5	reviewed	review	VERB
aiua-12856	31	6	by	by	ADP
aiua-12856	31	7	a	a	DET
aiua-12856	31	8	pathologist	pathologist	NOUN
aiua-12856	31	9	specialized	specialize	VERB
aiua-12856	31	10	in	in	ADP
aiua-12856	31	11	genitourinary	genitourinary	ADJ
aiua-12856	31	12	pathology	pathology	NOUN
aiua-12856	31	13	.	.	PUNCT
aiua-12856	32	1	all	all	DET
aiua-12856	32	2	research	research	NOUN
aiua-12856	32	3	was	be	AUX
aiua-12856	32	4	performed	perform	VERB
aiua-12856	32	5	in	in	ADP
aiua-12856	32	6	accordance	accordance	NOUN
aiua-12856	32	7	with	with	ADP
aiua-12856	32	8	relevant	relevant	ADJ
aiua-12856	32	9	national	national	ADJ
aiua-12856	32	10	and	and	CCONJ
aiua-12856	32	11	international	international	ADJ
aiua-12856	32	12	regulations	regulation	NOUN
aiua-12856	32	13	and	and	CCONJ
aiua-12856	32	14	informed	inform	VERB
aiua-12856	32	15	consent	consent	NOUN
aiua-12856	32	16	to	to	PART
aiua-12856	32	17	use	use	VERB
aiua-12856	32	18	the	the	DET
aiua-12856	32	19	pathology	pathology	NOUN
aiua-12856	32	20	material	material	NOUN
aiua-12856	32	21	was	be	AUX
aiua-12856	32	22	obtained	obtain	VERB
aiua-12856	32	23	from	from	ADP
aiua-12856	32	24	all	all	DET
aiua-12856	32	25	participants	participant	NOUN
aiua-12856	32	26	.	.	PUNCT
aiua-12856	33	1	the	the	DET
aiua-12856	33	2	research	research	NOUN
aiua-12856	33	3	was	be	AUX
aiua-12856	33	4	performed	perform	VERB
aiua-12856	33	5	in	in	ADP
aiua-12856	33	6	accordance	accordance	NOUN
aiua-12856	33	7	with	with	ADP
aiua-12856	33	8	the	the	DET
aiua-12856	33	9	declaration	declaration	NOUN
aiua-12856	33	10	of	of	ADP
aiua-12856	33	11	helsinki	helsinki	PROPN
aiua-12856	33	12	.	.	PUNCT
aiua-12856	34	1	immunohistochemistry	immunohistochemistry	PROPN
aiua-12856	34	2	pd	pd	PROPN
aiua-12856	34	3	-	-	PUNCT
aiua-12856	34	4	l1	l1	PROPN
aiua-12856	34	5	expression	expression	NOUN
aiua-12856	34	6	was	be	AUX
aiua-12856	34	7	assessed	assess	VERB
aiua-12856	34	8	by	by	ADP
aiua-12856	34	9	immunohistochemistry	immunohistochemistry	NOUN
aiua-12856	34	10	(	(	PUNCT
aiua-12856	34	11	ihc	ihc	PROPN
aiua-12856	34	12	)	)	PUNCT
aiua-12856	34	13	in	in	ADP
aiua-12856	34	14	formalin	formalin	NOUN
aiua-12856	34	15	-	-	PUNCT
aiua-12856	34	16	fixed	fix	VERB
aiua-12856	34	17	,	,	PUNCT
aiua-12856	34	18	paraffin	paraffin	NOUN
aiua-12856	34	19	-	-	PUNCT
aiua-12856	34	20	embedded	embed	VERB
aiua-12856	34	21	(	(	PUNCT
aiua-12856	34	22	ffpe	ffpe	NOUN
aiua-12856	34	23	)	)	PUNCT
aiua-12856	34	24	tumor	tumor	NOUN
aiua-12856	34	25	samples	sample	NOUN
aiua-12856	34	26	at	at	ADP
aiua-12856	34	27	our	our	PRON
aiua-12856	34	28	institution	institution	NOUN
aiua-12856	34	29	.	.	PUNCT
aiua-12856	35	1	pd	pd	PROPN
aiua-12856	35	2	-	-	PROPN
aiua-12856	35	3	l1	l1	PROPN
aiua-12856	35	4	ihc	ihc	PROPN
aiua-12856	35	5	22c3	22c3	NUM
aiua-12856	35	6	pharmdx	pharmdx	NOUN
aiua-12856	35	7	assay	assay	NOUN
aiua-12856	35	8	was	be	AUX
aiua-12856	35	9	performed	perform	VERB
aiua-12856	35	10	using	use	VERB
aiua-12856	35	11	a	a	DET
aiua-12856	35	12	monoclonal	monoclonal	NOUN
aiua-12856	35	13	mouse	mouse	NOUN
aiua-12856	35	14	anti	anti	ADJ
aiua-12856	35	15	-	-	ADJ
aiua-12856	35	16	pdl1	pdl1	ADJ
aiua-12856	35	17	clone	clone	NOUN
aiua-12856	35	18	22c3	22c3	NUM
aiua-12856	35	19	and	and	CCONJ
aiua-12856	35	20	a	a	DET
aiua-12856	35	21	validated	validate	VERB
aiua-12856	35	22	protocol	protocol	NOUN
aiua-12856	35	23	for	for	ADP
aiua-12856	35	24	ventana	ventana	PROPN
aiua-12856	35	25	benchmark	benchmark	PROPN
aiua-12856	35	26	ultra	ultra	ADJ
aiua-12856	35	27	platform	platform	NOUN
aiua-12856	35	28	.	.	PUNCT
aiua-12856	36	1	pd	pd	PROPN
aiua-12856	36	2	-	-	PUNCT
aiua-12856	36	3	l1	l1	PROPN
aiua-12856	36	4	protein	protein	NOUN
aiua-12856	36	5	expression	expression	NOUN
aiua-12856	36	6	was	be	AUX
aiua-12856	36	7	determined	determine	VERB
aiua-12856	36	8	by	by	ADP
aiua-12856	36	9	using	use	VERB
aiua-12856	36	10	a	a	DET
aiua-12856	36	11	combined	combine	VERB
aiua-12856	36	12	positive	positive	ADJ
aiua-12856	36	13	score	score	NOUN
aiua-12856	36	14	(	(	PUNCT
aiua-12856	36	15	cps	cps	PROPN
aiua-12856	36	16	)	)	PUNCT
aiua-12856	36	17	,	,	PUNCT
aiua-12856	36	18	counting	count	VERB
aiua-12856	36	19	the	the	DET
aiua-12856	36	20	number	number	NOUN
aiua-12856	36	21	of	of	ADP
aiua-12856	36	22	pd	pd	PROPN
aiua-12856	36	23	-	-	PUNCT
aiua-12856	36	24	l1	l1	PROPN
aiua-12856	36	25	staining	stain	VERB
aiua-12856	36	26	cells	cell	NOUN
aiua-12856	36	27	(	(	PUNCT
aiua-12856	36	28	tumor	tumor	NOUN
aiua-12856	36	29	cells	cell	NOUN
aiua-12856	36	30	,	,	PUNCT
aiua-12856	36	31	lymphocytes	lymphocyte	NOUN
aiua-12856	36	32	,	,	PUNCT
aiua-12856	36	33	macrophages	macrophage	NOUN
aiua-12856	36	34	)	)	PUNCT
aiua-12856	36	35	divided	divide	VERB
aiua-12856	36	36	by	by	ADP
aiua-12856	36	37	the	the	DET
aiua-12856	36	38	total	total	ADJ
aiua-12856	36	39	number	number	NOUN
aiua-12856	36	40	of	of	ADP
aiua-12856	36	41	viable	viable	ADJ
aiua-12856	36	42	tumor	tumor	NOUN
aiua-12856	36	43	cells	cell	NOUN
aiua-12856	36	44	,	,	PUNCT
aiua-12856	36	45	multiplied	multiply	VERB
aiua-12856	36	46	by	by	ADP
aiua-12856	36	47	100	100	NUM
aiua-12856	36	48	(	(	PUNCT
aiua-12856	36	49	e.g.	e.g.	ADV
aiua-12856	36	50	if	if	SCONJ
aiua-12856	36	51	1	1	NUM
aiua-12856	36	52	staining	stain	VERB
aiua-12856	36	53	cell	cell	NOUN
aiua-12856	36	54	was	be	AUX
aiua-12856	36	55	found	find	VERB
aiua-12856	36	56	out	out	ADP
aiua-12856	36	57	of	of	ADP
aiua-12856	36	58	100	100	NUM
aiua-12856	36	59	viable	viable	ADJ
aiua-12856	36	60	cells	cell	NOUN
aiua-12856	36	61	the	the	DET
aiua-12856	36	62	score	score	NOUN
aiua-12856	36	63	was	be	AUX
aiua-12856	36	64	1/100	1/100	NUM
aiua-12856	36	65	x	x	SYM
aiua-12856	36	66	100	100	NUM
aiua-12856	36	67	=	=	SYM
aiua-12856	36	68	1	1	NUM
aiua-12856	36	69	)	)	PUNCT
aiua-12856	36	70	.	.	PUNCT
aiua-12856	37	1	a	a	DET
aiua-12856	37	2	minimum	minimum	NOUN
aiua-12856	37	3	of	of	ADP
aiua-12856	37	4	100	100	NUM
aiua-12856	37	5	viable	viable	ADJ
aiua-12856	37	6	tumor	tumor	NOUN
aiua-12856	37	7	cells	cell	NOUN
aiua-12856	37	8	was	be	AUX
aiua-12856	37	9	present	present	ADJ
aiua-12856	37	10	in	in	ADP
aiua-12856	37	11	each	each	DET
aiua-12856	37	12	stained	stain	VERB
aiua-12856	37	13	slide	slide	NOUN
aiua-12856	37	14	for	for	ADP
aiua-12856	37	15	adequate	adequate	ADJ
aiua-12856	37	16	pd	pd	PROPN
aiua-12856	37	17	-	-	PROPN
aiua-12856	37	18	l1	l1	PROPN
aiua-12856	37	19	evaluation	evaluation	NOUN
aiua-12856	37	20	.	.	PUNCT
aiua-12856	38	1	pd	pd	PROPN
aiua-12856	38	2	-	-	PUNCT
aiua-12856	38	3	l1	l1	PROPN
aiua-12856	38	4	staining	stain	VERB
aiua-12856	38	5	was	be	AUX
aiua-12856	38	6	evaluated	evaluate	VERB
aiua-12856	38	7	as	as	ADP
aiua-12856	38	8	membranous	membranous	ADJ
aiua-12856	38	9	tumor	tumor	NOUN
aiua-12856	38	10	cell	cell	NOUN
aiua-12856	38	11	staining	stain	VERB
aiua-12856	38	12	and	and	CCONJ
aiua-12856	38	13	membranous	membranous	ADJ
aiua-12856	38	14	/	/	SYM
aiua-12856	38	15	cytoplasmic	cytoplasmic	ADJ
aiua-12856	38	16	staining	staining	NOUN
aiua-12856	38	17	of	of	ADP
aiua-12856	38	18	mononuclear	mononuclear	ADJ
aiua-12856	38	19	inflammatory	inflammatory	ADJ
aiua-12856	38	20	cells	cell	NOUN
aiua-12856	38	21	(	(	PUNCT
aiua-12856	38	22	mics	mic	NOUN
aiua-12856	38	23	)	)	PUNCT
aiua-12856	38	24	within	within	ADP
aiua-12856	38	25	tumor	tumor	NOUN
aiua-12856	38	26	nests	nest	NOUN
aiua-12856	38	27	and	and	CCONJ
aiua-12856	38	28	adjacent	adjacent	ADJ
aiua-12856	38	29	supporting	support	VERB
aiua-12856	38	30	stroma	stroma	NOUN
aiua-12856	38	31	.	.	PUNCT
aiua-12856	39	1	pd	pd	PROPN
aiua-12856	39	2	-	-	PROPN
aiua-12856	39	3	l1	l1	PROPN
aiua-12856	39	4	cps	cps	PROPN
aiua-12856	39	5	≥	≥	NUM
aiua-12856	39	6	1	1	NUM
aiua-12856	39	7	cases	case	NOUN
aiua-12856	39	8	were	be	AUX
aiua-12856	39	9	considered	consider	VERB
aiua-12856	39	10	when	when	SCONJ
aiua-12856	39	11	cps	cps	PROPN
aiua-12856	39	12	≥	≥	PROPN
aiua-12856	39	13	1	1	NUM
aiua-12856	39	14	.	.	PUNCT
aiua-12856	40	1	also	also	ADV
aiua-12856	40	2	,	,	PUNCT
aiua-12856	40	3	in	in	ADP
aiua-12856	40	4	all	all	DET
aiua-12856	40	5	cases	case	NOUN
aiua-12856	40	6	before	before	SCONJ
aiua-12856	40	7	2021	2021	NUM
aiua-12856	40	8	ihc	ihc	PROPN
aiua-12856	40	9	for	for	ADP
aiua-12856	40	10	p16	p16	NOUN
aiua-12856	40	11	was	be	AUX
aiua-12856	40	12	performed	perform	VERB
aiua-12856	40	13	on	on	ADP
aiua-12856	40	14	ventana	ventana	PROPN
aiua-12856	40	15	®	®	NOUN
aiua-12856	40	16	benchmark	benchmark	ADJ
aiua-12856	40	17	ultra	ultra	ADJ
aiua-12856	40	18	equipment	equipment	NOUN
aiua-12856	40	19	with	with	ADP
aiua-12856	40	20	the	the	DET
aiua-12856	40	21	ventana	ventana	PROPN
aiua-12856	40	22	®	®	NOUN
aiua-12856	40	23	optview	optview	NOUN
aiua-12856	40	24	dab	dab	PROPN
aiua-12856	40	25	ihc	ihc	PROPN
aiua-12856	40	26	detection	detection	PROPN
aiua-12856	40	27	kit	kit	NOUN
aiua-12856	40	28	(	(	PUNCT
aiua-12856	40	29	ref	ref	NOUN
aiua-12856	40	30	760	760	NUM
aiua-12856	40	31	-	-	NOUN
aiua-12856	40	32	700	700	NUM
aiua-12856	40	33	)	)	PUNCT
aiua-12856	40	34	.	.	PUNCT
aiua-12856	41	1	cc1	cc1	PROPN
aiua-12856	41	2	was	be	AUX
aiua-12856	41	3	used	use	VERB
aiua-12856	41	4	for	for	ADP
aiua-12856	41	5	antigen	antigen	ADJ
aiua-12856	41	6	retrieval	retrieval	NOUN
aiua-12856	41	7	(	(	PUNCT
aiua-12856	41	8	ar	ar	NOUN
aiua-12856	41	9	)	)	PUNCT
aiua-12856	41	10	and	and	CCONJ
aiua-12856	41	11	anti	anti	NOUN
aiua-12856	41	12	-	-	NOUN
aiua-12856	41	13	p16	p16	NOUN
aiua-12856	41	14	(	(	PUNCT
aiua-12856	41	15	roche	roche	PROPN
aiua-12856	41	16	ventana	ventana	PROPN
aiua-12856	41	17	®	®	NOUN
aiua-12856	41	18	clone	clone	NOUN
aiua-12856	41	19	e6h4	e6h4	AUX
aiua-12856	41	20	)	)	PUNCT
aiua-12856	41	21	was	be	AUX
aiua-12856	41	22	used	use	VERB
aiua-12856	41	23	.	.	PUNCT
aiua-12856	42	1	positive	positive	ADJ
aiua-12856	42	2	cases	case	NOUN
aiua-12856	42	3	were	be	AUX
aiua-12856	42	4	considered	consider	VERB
aiua-12856	42	5	if	if	SCONJ
aiua-12856	42	6	a	a	DET
aiua-12856	42	7	strong	strong	ADJ
aiua-12856	42	8	block	block	NOUN
aiua-12856	42	9	positivity	positivity	NOUN
aiua-12856	42	10	for	for	ADP
aiua-12856	42	11	p16	p16	NOUN
aiua-12856	42	12	was	be	AUX
aiua-12856	42	13	observed	observe	VERB
aiua-12856	42	14	.	.	PUNCT
aiua-12856	43	1	statistical	statistical	ADJ
aiua-12856	43	2	analysis	analysis	NOUN
aiua-12856	43	3	continuous	continuous	ADJ
aiua-12856	43	4	data	datum	NOUN
aiua-12856	43	5	were	be	AUX
aiua-12856	43	6	described	describe	VERB
aiua-12856	43	7	by	by	ADP
aiua-12856	43	8	median	median	PROPN
aiua-12856	43	9	and	and	CCONJ
aiua-12856	43	10	interquartile	interquartile	ADJ
aiua-12856	43	11	range	range	NOUN
aiua-12856	43	12	(	(	PUNCT
aiua-12856	43	13	iqr	iqr	NOUN
aiua-12856	43	14	)	)	PUNCT
aiua-12856	43	15	.	.	PUNCT
aiua-12856	44	1	categorical	categorical	ADJ
aiua-12856	44	2	data	datum	NOUN
aiua-12856	44	3	were	be	AUX
aiua-12856	44	4	presented	present	VERB
aiua-12856	44	5	by	by	ADP
aiua-12856	44	6	counts	count	NOUN
aiua-12856	44	7	and	and	CCONJ
aiua-12856	44	8	percentages	percentage	NOUN
aiua-12856	44	9	.	.	PUNCT
aiua-12856	45	1	comparisons	comparison	NOUN
aiua-12856	45	2	between	between	ADP
aiua-12856	45	3	continuous	continuous	ADJ
aiua-12856	45	4	data	datum	NOUN
aiua-12856	45	5	were	be	AUX
aiua-12856	45	6	performed	perform	VERB
aiua-12856	45	7	by	by	ADP
aiua-12856	45	8	the	the	DET
aiua-12856	45	9	mann	mann	PROPN
aiua-12856	45	10	-	-	PUNCT
aiua-12856	45	11	whitney	whitney	PROPN
aiua-12856	45	12	u	u	PROPN
aiua-12856	45	13	test	test	NOUN
aiua-12856	45	14	and	and	CCONJ
aiua-12856	45	15	categorical	categorical	ADJ
aiua-12856	45	16	data	datum	NOUN
aiua-12856	45	17	by	by	ADP
aiua-12856	45	18	pearson	pearson	PROPN
aiua-12856	45	19	's	's	PART
aiua-12856	45	20	chi	chi	NOUN
aiua-12856	45	21	-	-	PUNCT
aiua-12856	45	22	squared	square	VERB
aiua-12856	45	23	or	or	CCONJ
aiua-12856	45	24	fisher	fisher	NOUN
aiua-12856	45	25	's	's	PART
aiua-12856	45	26	exact	exact	ADJ
aiua-12856	45	27	test	test	NOUN
aiua-12856	45	28	,	,	PUNCT
aiua-12856	45	29	accordingly	accordingly	ADV
aiua-12856	45	30	.	.	PUNCT
aiua-12856	46	1	kaplan	kaplan	PROPN
aiua-12856	46	2	-	-	PUNCT
aiua-12856	46	3	meier	meier	PROPN
aiua-12856	46	4	curves	curve	NOUN
aiua-12856	46	5	were	be	AUX
aiua-12856	46	6	obtained	obtain	VERB
aiua-12856	46	7	to	to	PART
aiua-12856	46	8	estimate	estimate	VERB
aiua-12856	46	9	the	the	DET
aiua-12856	46	10	survival	survival	NOUN
aiua-12856	46	11	rates	rate	NOUN
aiua-12856	46	12	with	with	ADP
aiua-12856	46	13	statistical	statistical	ADJ
aiua-12856	46	14	significance	significance	NOUN
aiua-12856	46	15	evaluated	evaluate	VERB
aiua-12856	46	16	by	by	ADP
aiua-12856	46	17	the	the	DET
aiua-12856	46	18	log	log	NOUN
aiua-12856	46	19	-	-	PUNCT
aiua-12856	46	20	rank	rank	NOUN
aiua-12856	46	21	test	test	NOUN
aiua-12856	46	22	.	.	PUNCT
aiua-12856	47	1	a	a	DET
aiua-12856	47	2	p	p	X
aiua-12856	47	3	<	<	X
aiua-12856	47	4	0.05	0.05	NUM
aiua-12856	47	5	was	be	AUX
aiua-12856	47	6	defined	define	VERB
aiua-12856	47	7	as	as	ADP
aiua-12856	47	8	statistically	statistically	ADV
aiua-12856	47	9	significant	significant	ADJ
aiua-12856	47	10	.	.	PUNCT
aiua-12856	48	1	data	datum	NOUN
aiua-12856	48	2	was	be	AUX
aiua-12856	48	3	processed	process	VERB
aiua-12856	48	4	and	and	CCONJ
aiua-12856	48	5	analysed	analyse	VERB
aiua-12856	48	6	with	with	ADP
aiua-12856	48	7	ibm	ibm	PROPN
aiua-12856	48	8	-	-	PUNCT
aiua-12856	48	9	spss	spss	PROPN
aiua-12856	48	10	software	software	NOUN
aiua-12856	48	11	version	version	NOUN
aiua-12856	48	12	22.0	22.0	NUM
aiua-12856	48	13	.	.	PUNCT
aiua-12856	49	1	results	result	NOUN
aiua-12856	49	2	patient	patient	ADJ
aiua-12856	49	3	characteristics	characteristic	NOUN
aiua-12856	49	4	a	a	DET
aiua-12856	49	5	total	total	NOUN
aiua-12856	49	6	of	of	ADP
aiua-12856	49	7	34	34	NUM
aiua-12856	49	8	patients	patient	NOUN
aiua-12856	49	9	were	be	AUX
aiua-12856	49	10	eligible	eligible	ADJ
aiua-12856	49	11	for	for	ADP
aiua-12856	49	12	analysis	analysis	NOUN
aiua-12856	49	13	in	in	ADP
aiua-12856	49	14	this	this	DET
aiua-12856	49	15	study	study	NOUN
aiua-12856	49	16	.	.	PUNCT
aiua-12856	50	1	the	the	DET
aiua-12856	50	2	median	median	ADJ
aiua-12856	50	3	age	age	NOUN
aiua-12856	50	4	at	at	ADP
aiua-12856	50	5	diagnosis	diagnosis	NOUN
aiua-12856	50	6	was	be	AUX
aiua-12856	50	7	67	67	NUM
aiua-12856	50	8	years	year	NOUN
aiua-12856	50	9	(	(	PUNCT
aiua-12856	50	10	iqr	iqr	NOUN
aiua-12856	50	11	20	20	NUM
aiua-12856	50	12	)	)	PUNCT
aiua-12856	50	13	.	.	PUNCT
aiua-12856	51	1	the	the	DET
aiua-12856	51	2	median	median	ADJ
aiua-12856	51	3	size	size	NOUN
aiua-12856	51	4	of	of	ADP
aiua-12856	51	5	the	the	DET
aiua-12856	51	6	tumor	tumor	NOUN
aiua-12856	51	7	was	be	AUX
aiua-12856	51	8	3.0	3.0	NUM
aiua-12856	51	9	cm	cm	NOUN
aiua-12856	51	10	(	(	PUNCT
aiua-12856	51	11	iqr	iqr	NOUN
aiua-12856	51	12	3.3	3.3	NUM
aiua-12856	51	13	)	)	PUNCT
aiua-12856	51	14	.	.	PUNCT
aiua-12856	52	1	among	among	ADP
aiua-12856	52	2	the	the	DET
aiua-12856	52	3	patients	patient	NOUN
aiua-12856	52	4	,	,	PUNCT
aiua-12856	52	5	11	11	NUM
aiua-12856	52	6	were	be	AUX
aiua-12856	52	7	classified	classify	VERB
aiua-12856	52	8	as	as	ADP
aiua-12856	52	9	hpv	hpv	NOUN
aiua-12856	52	10	-	-	PUNCT
aiua-12856	52	11	associated	associate	VERB
aiua-12856	52	12	(	(	PUNCT
aiua-12856	52	13	p16	p16	NOUN
aiua-12856	52	14	positive	positive	ADJ
aiua-12856	52	15	)	)	PUNCT
aiua-12856	52	16	.	.	PUNCT
aiua-12856	53	1	twenty	twenty	NUM
aiua-12856	53	2	-	-	PUNCT
aiua-12856	53	3	two	two	NUM
aiua-12856	53	4	cases	case	NOUN
aiua-12856	53	5	were	be	AUX
aiua-12856	53	6	considered	consider	VERB
aiua-12856	53	7	to	to	PART
aiua-12856	53	8	be	be	AUX
aiua-12856	53	9	pd	pd	PROPN
aiua-12856	53	10	-	-	PROPN
aiua-12856	53	11	l1	l1	PROPN
aiua-12856	53	12	cps	cps	PROPN
aiua-12856	53	13	≥	≥	PROPN
aiua-12856	53	14	1	1	NUM
aiua-12856	53	15	.	.	PUNCT
aiua-12856	54	1	the	the	DET
aiua-12856	54	2	study	study	NOUN
aiua-12856	54	3	uniformly	uniformly	ADV
aiua-12856	54	4	recorded	record	VERB
aiua-12856	54	5	cases	case	NOUN
aiua-12856	54	6	across	across	ADP
aiua-12856	54	7	all	all	DET
aiua-12856	54	8	grades	grade	NOUN
aiua-12856	54	9	.	.	PUNCT
aiua-12856	55	1	regarding	regard	VERB
aiua-12856	55	2	pathological	pathological	ADJ
aiua-12856	55	3	stages	stage	NOUN
aiua-12856	55	4	,	,	PUNCT
aiua-12856	55	5	no	no	DET
aiua-12856	55	6	pt1b	pt1b	ADJ
aiua-12856	55	7	tumors	tumor	NOUN
aiua-12856	55	8	were	be	AUX
aiua-12856	55	9	observed	observe	VERB
aiua-12856	55	10	,	,	PUNCT
aiua-12856	55	11	but	but	CCONJ
aiua-12856	55	12	all	all	DET
aiua-12856	55	13	other	other	ADJ
aiua-12856	55	14	stages	stage	NOUN
aiua-12856	55	15	were	be	AUX
aiua-12856	55	16	represented	represent	VERB
aiua-12856	55	17	.	.	PUNCT
aiua-12856	56	1	a	a	DET
aiua-12856	56	2	partial	partial	ADJ
aiua-12856	56	3	penectomy	penectomy	NOUN
aiua-12856	56	4	was	be	AUX
aiua-12856	56	5	performed	perform	VERB
aiua-12856	56	6	in	in	ADP
aiua-12856	56	7	the	the	DET
aiua-12856	56	8	majority	majority	NOUN
aiua-12856	56	9	of	of	ADP
aiua-12856	56	10	the	the	DET
aiua-12856	56	11	cases	case	NOUN
aiua-12856	56	12	(	(	PUNCT
aiua-12856	56	13	70.6	70.6	NUM
aiua-12856	56	14	%	%	NOUN
aiua-12856	56	15	)	)	PUNCT
aiua-12856	56	16	and	and	CCONJ
aiua-12856	56	17	none	none	NOUN
aiua-12856	56	18	of	of	ADP
aiua-12856	56	19	the	the	DET
aiua-12856	56	20	patients	patient	NOUN
aiua-12856	56	21	had	have	VERB
aiua-12856	56	22	adjuvant	adjuvant	ADJ
aiua-12856	56	23	treatments	treatment	NOUN
aiua-12856	56	24	.	.	PUNCT
aiua-12856	57	1	clinicopathological	clinicopathological	ADJ
aiua-12856	57	2	and	and	CCONJ
aiua-12856	57	3	demographic	demographic	ADJ
aiua-12856	57	4	characteristics	characteristic	NOUN
aiua-12856	57	5	of	of	ADP
aiua-12856	57	6	the	the	DET
aiua-12856	57	7	cohort	cohort	NOUN
aiua-12856	57	8	are	be	AUX
aiua-12856	57	9	presented	present	VERB
aiua-12856	57	10	in	in	ADP
aiua-12856	57	11	table	table	NOUN
aiua-12856	57	12	1	1	NUM
aiua-12856	57	13	.	.	PUNCT
aiua-12856	58	1	association	association	NOUN
aiua-12856	58	2	of	of	ADP
aiua-12856	58	3	pd	pd	PROPN
aiua-12856	58	4	-	-	PROPN
aiua-12856	58	5	l1	l1	PROPN
aiua-12856	58	6	expression	expression	NOUN
aiua-12856	58	7	with	with	ADP
aiua-12856	58	8	clinicopathological	clinicopathological	ADJ
aiua-12856	58	9	features	feature	NOUN
aiua-12856	58	10	larger	large	ADJ
aiua-12856	58	11	tumors	tumor	NOUN
aiua-12856	58	12	(	(	PUNCT
aiua-12856	58	13	3.0	3.0	NUM
aiua-12856	58	14	cm	cm	NOUN
aiua-12856	58	15	in	in	ADP
aiua-12856	58	16	pd	pd	PROPN
aiua-12856	58	17	-	-	PROPN
aiua-12856	58	18	l1	l1	PROPN
aiua-12856	58	19	cps	cps	PROPN
aiua-12856	58	20	≥	≥	PROPN
aiua-12856	58	21	1	1	NUM
aiua-12856	58	22	vs	vs	ADP
aiua-12856	58	23	2.5	2.5	NUM
aiua-12856	58	24	cm	cm	NOUN
aiua-12856	58	25	in	in	ADP
aiua-12856	58	26	pdl1	pdl1	PROPN
aiua-12856	58	27	cps	cps	PROPN
aiua-12856	58	28	<	<	X
aiua-12856	58	29	1	1	NUM
aiua-12856	58	30	;	;	PUNCT
aiua-12856	58	31	p	p	NOUN
aiua-12856	58	32	=	=	NOUN
aiua-12856	58	33	0.662	0.662	NUM
aiua-12856	58	34	)	)	PUNCT
aiua-12856	58	35	,	,	PUNCT
aiua-12856	58	36	vascular	vascular	ADJ
aiua-12856	58	37	invasion	invasion	NOUN
aiua-12856	58	38	(	(	PUNCT
aiua-12856	58	39	36,4	36,4	NUM
aiua-12856	58	40	%	%	NOUN
aiua-12856	58	41	in	in	ADP
aiua-12856	58	42	pdl1	pdl1	PROPN
aiua-12856	58	43	cps	cps	PROPN
aiua-12856	58	44	≥	≥	PROPN
aiua-12856	58	45	1	1	NUM
aiua-12856	58	46	vs.	vs.	ADP
aiua-12856	58	47	25,0	25,0	NUM
aiua-12856	58	48	%	%	NOUN
aiua-12856	58	49	in	in	ADP
aiua-12856	58	50	pd	pd	PROPN
aiua-12856	58	51	-	-	PROPN
aiua-12856	58	52	l1	l1	PROPN
aiua-12856	58	53	cps	cps	PROPN
aiua-12856	58	54	<	<	X
aiua-12856	58	55	1	1	NUM
aiua-12856	58	56	;	;	PUNCT
aiua-12856	58	57	p	p	NOUN
aiua-12856	58	58	=	=	NOUN
aiua-12856	58	59	0.705	0.705	NUM
aiua-12856	58	60	)	)	PUNCT
aiua-12856	58	61	and	and	CCONJ
aiua-12856	58	62	perineural	perineural	ADJ
aiua-12856	58	63	invasion	invasion	NOUN
aiua-12856	58	64	(	(	PUNCT
aiua-12856	58	65	40.9	40.9	NUM
aiua-12856	58	66	%	%	NOUN
aiua-12856	58	67	in	in	ADP
aiua-12856	58	68	pd	pd	PROPN
aiua-12856	58	69	-	-	PROPN
aiua-12856	58	70	l1	l1	PROPN
aiua-12856	58	71	cps	cps	PROPN
aiua-12856	58	72	≥	≥	PROPN
aiua-12856	58	73	1	1	NUM
aiua-12856	58	74	vs.	vs.	ADP
aiua-12856	58	75	16,7	16,7	NUM
aiua-12856	58	76	%	%	NOUN
aiua-12856	58	77	in	in	ADP
aiua-12856	58	78	pd	pd	PROPN
aiua-12856	58	79	-	-	PROPN
aiua-12856	58	80	l1	l1	PROPN
aiua-12856	58	81	cps	cps	PROPN
aiua-12856	58	82	<	<	X
aiua-12856	58	83	1	1	NUM
aiua-12856	58	84	;	;	PUNCT
aiua-12856	58	85	p	p	NOUN
aiua-12856	58	86	=	=	NOUN
aiua-12856	58	87	0.252	0.252	NUM
aiua-12856	58	88	)	)	PUNCT
aiua-12856	58	89	were	be	AUX
aiua-12856	58	90	associated	associate	VERB
aiua-12856	58	91	with	with	ADP
aiua-12856	58	92	pdl1	pdl1	NOUN
aiua-12856	58	93	expression	expression	NOUN
aiua-12856	58	94	,	,	PUNCT
aiua-12856	58	95	but	but	CCONJ
aiua-12856	58	96	with	with	ADP
aiua-12856	58	97	no	no	DET
aiua-12856	58	98	statistical	statistical	ADJ
aiua-12856	58	99	significance	significance	NOUN
aiua-12856	58	100	.	.	PUNCT
aiua-12856	59	1	twenty	twenty	NUM
aiua-12856	59	2	-	-	PUNCT
aiua-12856	59	3	three	three	NUM
aiua-12856	59	4	patients	patient	NOUN
aiua-12856	59	5	underwent	undergo	VERB
aiua-12856	59	6	lymphadenectomy	lymphadenectomy	NOUN
aiua-12856	59	7	,	,	PUNCT
aiua-12856	59	8	with	with	ADP
aiua-12856	59	9	lymph	lymph	NOUN
aiua-12856	59	10	node	node	PROPN
aiua-12856	59	11	involvement	involvement	NOUN
aiua-12856	59	12	detected	detect	VERB
aiua-12856	59	13	in	in	ADP
aiua-12856	59	14	17	17	NUM
aiua-12856	59	15	of	of	ADP
aiua-12856	59	16	them	they	PRON
aiua-12856	59	17	.	.	PUNCT
aiua-12856	60	1	among	among	ADP
aiua-12856	60	2	those	those	PRON
aiua-12856	60	3	with	with	ADP
aiua-12856	60	4	lymph	lymph	NOUN
aiua-12856	60	5	node	node	NOUN
aiua-12856	60	6	involvement	involvement	NOUN
aiua-12856	60	7	,	,	PUNCT
aiua-12856	60	8	16	16	NUM
aiua-12856	60	9	patients	patient	NOUN
aiua-12856	60	10	were	be	AUX
aiua-12856	60	11	found	find	VERB
aiua-12856	60	12	to	to	PART
aiua-12856	60	13	be	be	AUX
aiua-12856	60	14	pd	pd	PROPN
aiua-12856	60	15	-	-	PROPN
aiua-12856	60	16	l1	l1	PROPN
aiua-12856	60	17	cps	cps	PROPN
aiua-12856	60	18	≥	≥	PROPN
aiua-12856	60	19	1	1	NUM
aiua-12856	60	20	.	.	PUNCT
aiua-12856	61	1	among	among	ADP
aiua-12856	61	2	the	the	DET
aiua-12856	61	3	high	high	ADJ
aiua-12856	61	4	-	-	PUNCT
aiua-12856	61	5	risk	risk	NOUN
aiua-12856	61	6	features	feature	NOUN
aiua-12856	61	7	,	,	PUNCT
aiua-12856	61	8	only	only	ADV
aiua-12856	61	9	lymph	lymph	NOUN
aiua-12856	61	10	node	node	PROPN
aiua-12856	61	11	involvement	involvement	NOUN
aiua-12856	61	12	had	have	VERB
aiua-12856	61	13	statistical	statistical	ADJ
aiua-12856	61	14	significance	significance	NOUN
aiua-12856	61	15	,	,	PUNCT
aiua-12856	61	16	with	with	ADP
aiua-12856	61	17	14	14	NUM
aiua-12856	61	18	out	out	ADP
aiua-12856	61	19	of	of	ADP
aiua-12856	61	20	22	22	NUM
aiua-12856	61	21	pd	pd	PROPN
aiua-12856	61	22	-	-	PROPN
aiua-12856	61	23	l1	l1	PROPN
aiua-12856	61	24	cps	cps	PROPN
aiua-12856	61	25	≥	≥	PROPN
aiua-12856	61	26	1	1	NUM
aiua-12856	61	27	patients	patient	NOUN
aiua-12856	61	28	(	(	PUNCT
aiua-12856	61	29	63.6	63.6	NUM
aiua-12856	61	30	%	%	NOUN
aiua-12856	61	31	)	)	PUNCT
aiua-12856	61	32	having	have	VERB
aiua-12856	61	33	lymph	lymph	NOUN
aiua-12856	61	34	node	node	NOUN
aiua-12856	61	35	metastases	metastasis	NOUN
aiua-12856	61	36	when	when	SCONJ
aiua-12856	61	37	lymphadenectomy	lymphadenectomy	NOUN
aiua-12856	61	38	was	be	AUX
aiua-12856	61	39	performed	perform	VERB
aiua-12856	61	40	(	(	PUNCT
aiua-12856	61	41	p	p	X
aiua-12856	61	42	=	=	NOUN
aiua-12856	61	43	0.031	0.031	NUM
aiua-12856	61	44	)	)	PUNCT
aiua-12856	61	45	.	.	PUNCT
aiua-12856	62	1	these	these	DET
aiua-12856	62	2	associations	association	NOUN
aiua-12856	62	3	are	be	AUX
aiua-12856	62	4	presented	present	VERB
aiua-12856	62	5	in	in	ADP
aiua-12856	62	6	table	table	NOUN
aiua-12856	62	7	2	2	NUM
aiua-12856	62	8	.	.	PUNCT
aiua-12856	62	9	association	association	NOUN
aiua-12856	62	10	of	of	ADP
aiua-12856	62	11	pd	pd	PROPN
aiua-12856	62	12	-	-	PROPN
aiua-12856	62	13	l1	l1	PROPN
aiua-12856	62	14	expression	expression	NOUN
aiua-12856	62	15	with	with	ADP
aiua-12856	62	16	survival	survival	NOUN
aiua-12856	62	17	outcomes	outcome	NOUN
aiua-12856	62	18	:	:	PUNCT
aiua-12856	62	19	with	with	ADP
aiua-12856	62	20	a	a	DET
aiua-12856	62	21	median	median	ADJ
aiua-12856	62	22	follow	follow	NOUN
aiua-12856	62	23	-	-	PUNCT
aiua-12856	62	24	up	up	NOUN
aiua-12856	62	25	of	of	ADP
aiua-12856	62	26	16	16	NUM
aiua-12856	62	27	months	month	NOUN
aiua-12856	62	28	(	(	PUNCT
aiua-12856	62	29	iqr	iqr	NOUN
aiua-12856	62	30	27.5	27.5	NUM
aiua-12856	62	31	)	)	PUNCT
aiua-12856	62	32	,	,	PUNCT
aiua-12856	62	33	pdl1	pdl1	PROPN
aiua-12856	62	34	cps	cps	PROPN
aiua-12856	62	35	≥	≥	PROPN
aiua-12856	62	36	1	1	NUM
aiua-12856	62	37	patients	patient	NOUN
aiua-12856	62	38	had	have	VERB
aiua-12856	62	39	worse	bad	ADJ
aiua-12856	62	40	overall	overall	ADJ
aiua-12856	62	41	survival	survival	NOUN
aiua-12856	62	42	(	(	PUNCT
aiua-12856	62	43	53.4	53.4	NUM
aiua-12856	62	44	table	table	NOUN
aiua-12856	62	45	1	1	NUM
aiua-12856	62	46	.	.	PUNCT
aiua-12856	63	1	clinical	clinical	ADJ
aiua-12856	63	2	and	and	CCONJ
aiua-12856	63	3	pathological	pathological	ADJ
aiua-12856	63	4	characteristics	characteristic	NOUN
aiua-12856	63	5	.	.	PUNCT
aiua-12856	64	1	characteristic	characteristic	ADJ
aiua-12856	64	2	total	total	ADJ
aiua-12856	64	3	sample	sample	NOUN
aiua-12856	64	4	(	(	PUNCT
aiua-12856	64	5	n	n	NOUN
aiua-12856	64	6	=	=	SYM
aiua-12856	64	7	34	34	NUM
aiua-12856	64	8	)	)	PUNCT
aiua-12856	64	9	median	median	ADJ
aiua-12856	64	10	age	age	NOUN
aiua-12856	64	11	at	at	ADP
aiua-12856	64	12	surgery	surgery	NOUN
aiua-12856	64	13	,	,	PUNCT
aiua-12856	64	14	yr	yr	PROPN
aiua-12856	64	15	67	67	NUM
aiua-12856	64	16	(	(	PUNCT
aiua-12856	64	17	iqr	iqr	NOUN
aiua-12856	64	18	20	20	NUM
aiua-12856	64	19	)	)	PUNCT
aiua-12856	64	20	high	high	ADJ
aiua-12856	64	21	-	-	PUNCT
aiua-12856	64	22	risk	risk	NOUN
aiua-12856	64	23	hpv	hpv	NOUN
aiua-12856	64	24	status	status	NOUN
aiua-12856	64	25	,	,	PUNCT
aiua-12856	64	26	n	n	PROPN
aiua-12856	64	27	(	(	PUNCT
aiua-12856	64	28	%	%	INTJ
aiua-12856	64	29	)	)	PUNCT
aiua-12856	64	30	negative	negative	ADJ
aiua-12856	64	31	23	23	NUM
aiua-12856	64	32	(	(	PUNCT
aiua-12856	64	33	67.6	67.6	NUM
aiua-12856	64	34	%	%	NOUN
aiua-12856	64	35	)	)	PUNCT
aiua-12856	64	36	positive	positive	ADJ
aiua-12856	64	37	11	11	NUM
aiua-12856	64	38	(	(	PUNCT
aiua-12856	64	39	32.4	32.4	NUM
aiua-12856	64	40	%	%	NOUN
aiua-12856	64	41	)	)	PUNCT
aiua-12856	64	42	pd	pd	PROPN
aiua-12856	64	43	-	-	PUNCT
aiua-12856	64	44	l1	l1	PROPN
aiua-12856	64	45	status	status	NOUN
aiua-12856	64	46	,	,	PUNCT
aiua-12856	64	47	n	n	PROPN
aiua-12856	64	48	(	(	PUNCT
aiua-12856	64	49	%	%	INTJ
aiua-12856	64	50	)	)	PUNCT
aiua-12856	64	51	cps	cp	NOUN
aiua-12856	64	52	<	<	X
aiua-12856	64	53	1	1	NUM
aiua-12856	64	54	12	12	NUM
aiua-12856	64	55	(	(	PUNCT
aiua-12856	64	56	35.3	35.3	NUM
aiua-12856	64	57	%	%	NOUN
aiua-12856	64	58	)	)	PUNCT
aiua-12856	64	59	cps	cps	PROPN
aiua-12856	64	60	≥	≥	NUM
aiua-12856	64	61	1	1	NUM
aiua-12856	64	62	22	22	NUM
aiua-12856	64	63	(	(	PUNCT
aiua-12856	64	64	64.7	64.7	NUM
aiua-12856	64	65	%	%	NOUN
aiua-12856	64	66	)	)	PUNCT
aiua-12856	64	67	median	median	ADJ
aiua-12856	64	68	tumor	tumor	NOUN
aiua-12856	64	69	size	size	NOUN
aiua-12856	64	70	,	,	PUNCT
aiua-12856	64	71	cm	cm	NOUN
aiua-12856	64	72	3	3	NUM
aiua-12856	64	73	(	(	PUNCT
aiua-12856	64	74	iqr	iqr	NOUN
aiua-12856	64	75	3.3	3.3	NUM
aiua-12856	64	76	)	)	PUNCT
aiua-12856	64	77	tumor	tumor	NOUN
aiua-12856	64	78	grade	grade	NOUN
aiua-12856	64	79	,	,	PUNCT
aiua-12856	64	80	n	n	CCONJ
aiua-12856	64	81	(	(	PUNCT
aiua-12856	64	82	%	%	INTJ
aiua-12856	64	83	)	)	PUNCT
aiua-12856	64	84	1	1	NUM
aiua-12856	64	85	11	11	NUM
aiua-12856	64	86	(	(	PUNCT
aiua-12856	64	87	32.4	32.4	NUM
aiua-12856	64	88	%	%	NOUN
aiua-12856	64	89	)	)	PUNCT
aiua-12856	64	90	2	2	NUM
aiua-12856	64	91	14	14	NUM
aiua-12856	64	92	(	(	PUNCT
aiua-12856	64	93	41.2	41.2	NUM
aiua-12856	64	94	%	%	NOUN
aiua-12856	64	95	)	)	PUNCT
aiua-12856	64	96	3	3	NUM
aiua-12856	64	97	8	8	NUM
aiua-12856	64	98	(	(	PUNCT
aiua-12856	64	99	23.5	23.5	NUM
aiua-12856	64	100	%	%	NOUN
aiua-12856	64	101	)	)	PUNCT
aiua-12856	64	102	4	4	NUM
aiua-12856	64	103	1	1	NUM
aiua-12856	64	104	(	(	PUNCT
aiua-12856	64	105	2.9	2.9	NUM
aiua-12856	64	106	%	%	NOUN
aiua-12856	64	107	)	)	PUNCT
aiua-12856	64	108	vascular	vascular	ADJ
aiua-12856	64	109	invasion	invasion	NOUN
aiua-12856	64	110	,	,	PUNCT
aiua-12856	64	111	n	n	CCONJ
aiua-12856	64	112	(	(	PUNCT
aiua-12856	64	113	%	%	INTJ
aiua-12856	64	114	)	)	PUNCT
aiua-12856	65	1	no	no	DET
aiua-12856	65	2	23	23	NUM
aiua-12856	65	3	(	(	PUNCT
aiua-12856	65	4	67.6	67.6	NUM
aiua-12856	65	5	%	%	NOUN
aiua-12856	65	6	)	)	PUNCT
aiua-12856	66	1	yes	yes	INTJ
aiua-12856	66	2	11	11	NUM
aiua-12856	66	3	(	(	PUNCT
aiua-12856	66	4	32.4	32.4	NUM
aiua-12856	66	5	%	%	NOUN
aiua-12856	66	6	)	)	PUNCT
aiua-12856	67	1	perineural	perineural	ADJ
aiua-12856	67	2	invasion	invasion	NOUN
aiua-12856	67	3	,	,	PUNCT
aiua-12856	67	4	n	n	CCONJ
aiua-12856	67	5	(	(	PUNCT
aiua-12856	67	6	%	%	INTJ
aiua-12856	67	7	)	)	PUNCT
aiua-12856	68	1	no	no	DET
aiua-12856	68	2	23	23	NUM
aiua-12856	68	3	(	(	PUNCT
aiua-12856	68	4	67.6	67.6	NUM
aiua-12856	68	5	%	%	NOUN
aiua-12856	68	6	)	)	PUNCT
aiua-12856	69	1	yes	yes	INTJ
aiua-12856	69	2	11	11	NUM
aiua-12856	69	3	(	(	PUNCT
aiua-12856	69	4	32.4	32.4	NUM
aiua-12856	69	5	%	%	NOUN
aiua-12856	69	6	)	)	PUNCT
aiua-12856	70	1	pt	pt	NOUN
aiua-12856	70	2	stage	stage	NOUN
aiua-12856	70	3	,	,	PUNCT
aiua-12856	70	4	n	n	CCONJ
aiua-12856	70	5	(	(	PUNCT
aiua-12856	70	6	%	%	INTJ
aiua-12856	70	7	)	)	PUNCT
aiua-12856	70	8	1a	1a	PROPN
aiua-12856	70	9	9	9	NUM
aiua-12856	70	10	(	(	PUNCT
aiua-12856	70	11	26.5	26.5	NUM
aiua-12856	70	12	%	%	NOUN
aiua-12856	70	13	)	)	PUNCT
aiua-12856	70	14	2	2	NUM
aiua-12856	70	15	11	11	NUM
aiua-12856	70	16	(	(	PUNCT
aiua-12856	70	17	32.4	32.4	NUM
aiua-12856	70	18	%	%	NOUN
aiua-12856	70	19	)	)	PUNCT
aiua-12856	70	20	3	3	NUM
aiua-12856	70	21	14	14	NUM
aiua-12856	70	22	(	(	PUNCT
aiua-12856	70	23	41.2	41.2	NUM
aiua-12856	70	24	%	%	NOUN
aiua-12856	70	25	)	)	PUNCT
aiua-12856	70	26	lymph	lymph	NOUN
aiua-12856	70	27	node	node	NOUN
aiua-12856	70	28	involvement	involvement	NOUN
aiua-12856	70	29	,	,	PUNCT
aiua-12856	70	30	n	n	CCONJ
aiua-12856	70	31	(	(	PUNCT
aiua-12856	70	32	%	%	INTJ
aiua-12856	70	33	)	)	PUNCT
aiua-12856	70	34	no	no	DET
aiua-12856	70	35	17	17	NUM
aiua-12856	70	36	(	(	PUNCT
aiua-12856	70	37	50.0	50.0	NUM
aiua-12856	70	38	%	%	NOUN
aiua-12856	70	39	)	)	PUNCT
aiua-12856	71	1	yes	yes	INTJ
aiua-12856	71	2	17	17	NUM
aiua-12856	71	3	(	(	PUNCT
aiua-12856	71	4	50.0	50.0	NUM
aiua-12856	71	5	%	%	NOUN
aiua-12856	71	6	)	)	PUNCT
aiua-12856	71	7	treatment	treatment	NOUN
aiua-12856	71	8	,	,	PUNCT
aiua-12856	71	9	n	n	CCONJ
aiua-12856	71	10	(	(	PUNCT
aiua-12856	71	11	%	%	INTJ
aiua-12856	71	12	)	)	PUNCT
aiua-12856	71	13	glansectomy	glansectomy	NOUN
aiua-12856	71	14	6	6	NUM
aiua-12856	71	15	(	(	PUNCT
aiua-12856	71	16	17.6	17.6	NUM
aiua-12856	71	17	%	%	NOUN
aiua-12856	71	18	)	)	PUNCT
aiua-12856	71	19	partial	partial	ADJ
aiua-12856	71	20	penectomy	penectomy	NOUN
aiua-12856	71	21	24	24	NUM
aiua-12856	71	22	(	(	PUNCT
aiua-12856	71	23	70.6	70.6	NUM
aiua-12856	71	24	%	%	NOUN
aiua-12856	71	25	)	)	PUNCT
aiua-12856	71	26	total	total	ADJ
aiua-12856	71	27	penectomy	penectomy	NOUN
aiua-12856	71	28	4	4	NUM
aiua-12856	71	29	(	(	PUNCT
aiua-12856	71	30	11.8	11.8	NUM
aiua-12856	71	31	%	%	NOUN
aiua-12856	71	32	)	)	PUNCT
aiua-12856	71	33	archivio	archivio	NOUN
aiua-12856	71	34	italiano	italiano	X
aiua-12856	71	35	di	di	X
aiua-12856	71	36	urologia	urologia	PROPN
aiua-12856	71	37	e	e	PROPN
aiua-12856	71	38	andrologia	andrologia	NOUN
aiua-12856	71	39	2024	2024	NUM
aiua-12856	71	40	;	;	PUNCT
aiua-12856	71	41	96(3):12856	96(3):12856	NUM
aiua-12856	71	42	3	3	NUM
aiua-12856	71	43	programmed	program	VERB
aiua-12856	71	44	death	death	NOUN
aiua-12856	71	45	-	-	PUNCT
aiua-12856	71	46	ligand	ligand	NOUN
aiua-12856	71	47	expression	expression	NOUN
aiua-12856	71	48	and	and	CCONJ
aiua-12856	71	49	lymph	lymph	NOUN
aiua-12856	71	50	node	node	ADJ
aiua-12856	71	51	involvement	involvement	NOUN
aiua-12856	71	52	in	in	ADP
aiua-12856	71	53	penile	penile	ADJ
aiua-12856	71	54	squamous	squamous	ADJ
aiua-12856	71	55	cell	cell	NOUN
aiua-12856	71	56	carcinoma	carcinoma	NOUN
aiua-12856	71	57	months	month	NOUN
aiua-12856	71	58	vs	vs	ADP
aiua-12856	71	59	75.9	75.9	NUM
aiua-12856	71	60	months	month	NOUN
aiua-12856	71	61	)	)	PUNCT
aiua-12856	71	62	,	,	PUNCT
aiua-12856	71	63	but	but	CCONJ
aiua-12856	71	64	statistical	statistical	ADJ
aiua-12856	71	65	significance	significance	NOUN
aiua-12856	71	66	could	could	AUX
aiua-12856	71	67	not	not	PART
aiua-12856	71	68	be	be	AUX
aiua-12856	71	69	inferred	infer	VERB
aiua-12856	71	70	(	(	PUNCT
aiua-12856	71	71	p	p	X
aiua-12856	71	72	=	=	NOUN
aiua-12856	71	73	0.188	0.188	NUM
aiua-12856	71	74	)	)	PUNCT
aiua-12856	71	75	.	.	PUNCT
aiua-12856	72	1	the	the	DET
aiua-12856	72	2	survival	survival	NOUN
aiua-12856	72	3	curves	curve	NOUN
aiua-12856	72	4	are	be	AUX
aiua-12856	72	5	presented	present	VERB
aiua-12856	72	6	in	in	ADP
aiua-12856	72	7	figure	figure	NOUN
aiua-12856	72	8	1	1	NUM
aiua-12856	72	9	.	.	PUNCT
aiua-12856	73	1	discussion	discussion	VERB
aiua-12856	73	2	the	the	DET
aiua-12856	73	3	rarity	rarity	NOUN
aiua-12856	73	4	of	of	ADP
aiua-12856	73	5	penile	penile	ADJ
aiua-12856	73	6	cancer	cancer	NOUN
aiua-12856	73	7	in	in	ADP
aiua-12856	73	8	western	western	ADJ
aiua-12856	73	9	countries	country	NOUN
aiua-12856	73	10	poses	pose	VERB
aiua-12856	73	11	challenges	challenge	NOUN
aiua-12856	73	12	in	in	ADP
aiua-12856	73	13	understanding	understand	VERB
aiua-12856	73	14	its	its	PRON
aiua-12856	73	15	biology	biology	NOUN
aiua-12856	73	16	and	and	CCONJ
aiua-12856	73	17	optimal	optimal	ADJ
aiua-12856	73	18	management	management	NOUN
aiua-12856	73	19	strategies	strategy	NOUN
aiua-12856	73	20	.	.	PUNCT
aiua-12856	74	1	our	our	PRON
aiua-12856	74	2	study	study	NOUN
aiua-12856	74	3	aimed	aim	VERB
aiua-12856	74	4	to	to	PART
aiua-12856	74	5	find	find	VERB
aiua-12856	74	6	an	an	DET
aiua-12856	74	7	association	association	NOUN
aiua-12856	74	8	between	between	ADP
aiua-12856	74	9	pd	pd	PROPN
aiua-12856	74	10	-	-	PUNCT
aiua-12856	74	11	l1	l1	PROPN
aiua-12856	74	12	status	status	NOUN
aiua-12856	74	13	and	and	CCONJ
aiua-12856	74	14	clinicopathological	clinicopathological	ADJ
aiua-12856	74	15	characteristics	characteristic	NOUN
aiua-12856	74	16	of	of	ADP
aiua-12856	74	17	penile	penile	ADJ
aiua-12856	74	18	sqcc	sqcc	NOUN
aiua-12856	74	19	,	,	PUNCT
aiua-12856	74	20	as	as	ADV
aiua-12856	74	21	well	well	ADV
aiua-12856	74	22	as	as	ADP
aiua-12856	74	23	associated	associate	VERB
aiua-12856	74	24	prognostic	prognostic	ADJ
aiua-12856	74	25	implications	implication	NOUN
aiua-12856	74	26	.	.	PUNCT
aiua-12856	75	1	in	in	ADP
aiua-12856	75	2	fact	fact	NOUN
aiua-12856	75	3	,	,	PUNCT
aiua-12856	75	4	our	our	PRON
aiua-12856	75	5	results	result	NOUN
aiua-12856	75	6	showed	show	VERB
aiua-12856	75	7	a	a	DET
aiua-12856	75	8	trend	trend	NOUN
aiua-12856	75	9	towards	towards	ADP
aiua-12856	75	10	worse	bad	ADJ
aiua-12856	75	11	clinical	clinical	ADJ
aiua-12856	75	12	features	feature	NOUN
aiua-12856	75	13	and	and	CCONJ
aiua-12856	75	14	worse	bad	ADJ
aiua-12856	75	15	survival	survival	NOUN
aiua-12856	75	16	in	in	ADP
aiua-12856	75	17	pdl1	pdl1	PROPN
aiua-12856	75	18	cps	cps	PROPN
aiua-12856	75	19	≥	≥	PROPN
aiua-12856	75	20	1	1	NUM
aiua-12856	75	21	patients	patient	NOUN
aiua-12856	75	22	,	,	PUNCT
aiua-12856	75	23	as	as	ADV
aiua-12856	75	24	well	well	ADV
aiua-12856	75	25	as	as	ADP
aiua-12856	75	26	a	a	DET
aiua-12856	75	27	significant	significant	ADJ
aiua-12856	75	28	association	association	NOUN
aiua-12856	75	29	between	between	ADP
aiua-12856	75	30	pd	pd	PROPN
aiua-12856	75	31	-	-	PUNCT
aiua-12856	75	32	l1	l1	PROPN
aiua-12856	75	33	status	status	NOUN
aiua-12856	75	34	and	and	CCONJ
aiua-12856	75	35	lymph	lymph	NOUN
aiua-12856	75	36	node	node	ADJ
aiua-12856	75	37	involvement	involvement	NOUN
aiua-12856	75	38	.	.	PUNCT
aiua-12856	76	1	the	the	DET
aiua-12856	76	2	association	association	NOUN
aiua-12856	76	3	between	between	ADP
aiua-12856	76	4	pd	pd	PROPN
aiua-12856	76	5	-	-	PROPN
aiua-12856	76	6	l1	l1	PROPN
aiua-12856	76	7	expression	expression	NOUN
aiua-12856	76	8	and	and	CCONJ
aiua-12856	76	9	clinicopathological	clinicopathological	ADJ
aiua-12856	76	10	features	feature	NOUN
aiua-12856	76	11	observed	observe	VERB
aiua-12856	76	12	in	in	ADP
aiua-12856	76	13	our	our	PRON
aiua-12856	76	14	study	study	NOUN
aiua-12856	76	15	is	be	AUX
aiua-12856	76	16	consistent	consistent	ADJ
aiua-12856	76	17	with	with	ADP
aiua-12856	76	18	previous	previous	ADJ
aiua-12856	76	19	research	research	NOUN
aiua-12856	76	20	in	in	ADP
aiua-12856	76	21	various	various	ADJ
aiua-12856	76	22	cancer	cancer	NOUN
aiua-12856	76	23	types	type	NOUN
aiua-12856	76	24	,	,	PUNCT
aiua-12856	76	25	including	include	VERB
aiua-12856	76	26	studies	study	NOUN
aiua-12856	76	27	conducted	conduct	VERB
aiua-12856	76	28	in	in	ADP
aiua-12856	76	29	penile	penile	ADJ
aiua-12856	76	30	cancer	cancer	NOUN
aiua-12856	76	31	(	(	PUNCT
aiua-12856	76	32	9	9	NUM
aiua-12856	76	33	,	,	PUNCT
aiua-12856	76	34	10	10	NUM
aiua-12856	76	35	)	)	PUNCT
aiua-12856	76	36	.	.	PUNCT
aiua-12856	77	1	we	we	PRON
aiua-12856	77	2	found	find	VERB
aiua-12856	77	3	a	a	DET
aiua-12856	77	4	trend	trend	NOUN
aiua-12856	77	5	towards	towards	ADP
aiua-12856	77	6	larger	large	ADJ
aiua-12856	77	7	tumor	tumor	NOUN
aiua-12856	77	8	size	size	NOUN
aiua-12856	77	9	,	,	PUNCT
aiua-12856	77	10	vascular	vascular	ADJ
aiua-12856	77	11	invasion	invasion	NOUN
aiua-12856	77	12	,	,	PUNCT
aiua-12856	77	13	and	and	CCONJ
aiua-12856	77	14	perineural	perineural	ADJ
aiua-12856	77	15	invasion	invasion	NOUN
aiua-12856	77	16	in	in	ADP
aiua-12856	77	17	patients	patient	NOUN
aiua-12856	77	18	with	with	ADP
aiua-12856	77	19	pd	pd	PROPN
aiua-12856	77	20	-	-	PROPN
aiua-12856	77	21	l1	l1	PROPN
aiua-12856	77	22	cps	cps	PROPN
aiua-12856	77	23	≥	≥	PROPN
aiua-12856	77	24	1	1	NUM
aiua-12856	77	25	tumors	tumor	NOUN
aiua-12856	77	26	,	,	PUNCT
aiua-12856	77	27	although	although	SCONJ
aiua-12856	77	28	statistical	statistical	ADJ
aiua-12856	77	29	significance	significance	NOUN
aiua-12856	77	30	was	be	AUX
aiua-12856	77	31	not	not	PART
aiua-12856	77	32	achieved	achieve	VERB
aiua-12856	77	33	,	,	PUNCT
aiua-12856	77	34	probably	probably	ADV
aiua-12856	77	35	due	due	ADP
aiua-12856	77	36	to	to	ADP
aiua-12856	77	37	the	the	DET
aiua-12856	77	38	low	low	ADJ
aiua-12856	77	39	number	number	NOUN
aiua-12856	77	40	of	of	ADP
aiua-12856	77	41	patients	patient	NOUN
aiua-12856	77	42	in	in	ADP
aiua-12856	77	43	our	our	PRON
aiua-12856	77	44	cohort	cohort	NOUN
aiua-12856	77	45	.	.	PUNCT
aiua-12856	78	1	these	these	DET
aiua-12856	78	2	findings	finding	NOUN
aiua-12856	78	3	are	be	AUX
aiua-12856	78	4	consistent	consistent	ADJ
aiua-12856	78	5	with	with	ADP
aiua-12856	78	6	the	the	DET
aiua-12856	78	7	largest	large	ADJ
aiua-12856	78	8	cohort	cohort	NOUN
aiua-12856	78	9	,	,	PUNCT
aiua-12856	78	10	to	to	ADP
aiua-12856	78	11	our	our	PRON
aiua-12856	78	12	knowledge	knowledge	NOUN
aiua-12856	78	13	,	,	PUNCT
aiua-12856	78	14	published	publish	VERB
aiua-12856	78	15	by	by	ADP
aiua-12856	78	16	sabina	sabina	PROPN
aiua-12856	78	17	davidsson	davidsson	PROPN
aiua-12856	78	18	and	and	CCONJ
aiua-12856	78	19	colleagues	colleague	NOUN
aiua-12856	78	20	,	,	PUNCT
aiua-12856	78	21	who	who	PRON
aiua-12856	78	22	analysed	analyse	VERB
aiua-12856	78	23	222	222	NUM
aiua-12856	78	24	cases	case	NOUN
aiua-12856	78	25	of	of	ADP
aiua-12856	78	26	penile	penile	ADJ
aiua-12856	78	27	squamous	squamous	ADJ
aiua-12856	78	28	cell	cell	NOUN
aiua-12856	78	29	carcinoma	carcinoma	NOUN
aiua-12856	78	30	(	(	PUNCT
aiua-12856	78	31	sqcc	sqcc	NOUN
aiua-12856	78	32	)	)	PUNCT
aiua-12856	78	33	(	(	PUNCT
aiua-12856	78	34	8)	8)	NUM
aiua-12856	78	35	.	.	PUNCT
aiua-12856	79	1	this	this	PRON
aiua-12856	79	2	suggests	suggest	VERB
aiua-12856	79	3	a	a	DET
aiua-12856	79	4	potential	potential	ADJ
aiua-12856	79	5	link	link	NOUN
aiua-12856	79	6	between	between	ADP
aiua-12856	79	7	pd	pd	PROPN
aiua-12856	79	8	-	-	PROPN
aiua-12856	79	9	l1	l1	PROPN
aiua-12856	79	10	expression	expression	NOUN
aiua-12856	79	11	and	and	CCONJ
aiua-12856	79	12	aggressive	aggressive	ADJ
aiua-12856	79	13	tumor	tumor	NOUN
aiua-12856	79	14	behaviour	behaviour	NOUN
aiua-12856	79	15	,	,	PUNCT
aiua-12856	79	16	which	which	PRON
aiua-12856	79	17	poses	pose	VERB
aiua-12856	79	18	the	the	DET
aiua-12856	79	19	question	question	NOUN
aiua-12856	79	20	regarding	regard	VERB
aiua-12856	79	21	the	the	DET
aiua-12856	79	22	need	need	NOUN
aiua-12856	79	23	for	for	ADP
aiua-12856	79	24	a	a	DET
aiua-12856	79	25	different	different	ADJ
aiua-12856	79	26	treatment	treatment	NOUN
aiua-12856	79	27	pathway	pathway	NOUN
aiua-12856	79	28	in	in	ADP
aiua-12856	79	29	these	these	DET
aiua-12856	79	30	patients	patient	NOUN
aiua-12856	79	31	.	.	PUNCT
aiua-12856	80	1	a	a	DET
aiua-12856	80	2	novel	novel	ADJ
aiua-12856	80	3	observation	observation	NOUN
aiua-12856	80	4	in	in	ADP
aiua-12856	80	5	our	our	PRON
aiua-12856	80	6	study	study	NOUN
aiua-12856	80	7	is	be	AUX
aiua-12856	80	8	the	the	DET
aiua-12856	80	9	significant	significant	ADJ
aiua-12856	80	10	association	association	NOUN
aiua-12856	80	11	between	between	ADP
aiua-12856	80	12	pd	pd	PROPN
aiua-12856	80	13	-	-	PROPN
aiua-12856	80	14	l1	l1	PROPN
aiua-12856	80	15	expression	expression	NOUN
aiua-12856	80	16	and	and	CCONJ
aiua-12856	80	17	lymph	lymph	NOUN
aiua-12856	80	18	node	node	ADJ
aiua-12856	80	19	involvement	involvement	NOUN
aiua-12856	80	20	.	.	PUNCT
aiua-12856	81	1	we	we	PRON
aiua-12856	81	2	found	find	VERB
aiua-12856	81	3	that	that	SCONJ
aiua-12856	81	4	a	a	DET
aiua-12856	81	5	higher	high	ADJ
aiua-12856	81	6	proportion	proportion	NOUN
aiua-12856	81	7	of	of	ADP
aiua-12856	81	8	patients	patient	NOUN
aiua-12856	81	9	with	with	ADP
aiua-12856	81	10	pd	pd	PROPN
aiua-12856	81	11	-	-	PROPN
aiua-12856	81	12	l1	l1	PROPN
aiua-12856	81	13	cps	cps	PROPN
aiua-12856	81	14	≥	≥	PROPN
aiua-12856	81	15	1	1	NUM
aiua-12856	81	16	tumors	tumor	NOUN
aiua-12856	81	17	had	have	AUX
aiua-12856	81	18	lymph	lymph	NOUN
aiua-12856	81	19	node	node	ADJ
aiua-12856	81	20	metastases	metastasis	NOUN
aiua-12856	81	21	upon	upon	SCONJ
aiua-12856	81	22	lymphadenectomy	lymphadenectomy	NOUN
aiua-12856	81	23	compared	compare	VERB
aiua-12856	81	24	to	to	ADP
aiua-12856	81	25	those	those	PRON
aiua-12856	81	26	with	with	ADP
aiua-12856	81	27	pd	pd	PROPN
aiua-12856	81	28	-	-	PROPN
aiua-12856	81	29	l1	l1	PROPN
aiua-12856	81	30	cps	cps	PROPN
aiua-12856	81	31	<	<	X
aiua-12856	81	32	1	1	NUM
aiua-12856	81	33	tumors	tumor	NOUN
aiua-12856	81	34	,	,	PUNCT
aiua-12856	81	35	with	with	ADP
aiua-12856	81	36	14	14	NUM
aiua-12856	81	37	out	out	ADP
aiua-12856	81	38	of	of	ADP
aiua-12856	81	39	22	22	NUM
aiua-12856	81	40	pd	pd	PROPN
aiua-12856	81	41	-	-	PROPN
aiua-12856	81	42	l1	l1	PROPN
aiua-12856	81	43	cps	cps	PROPN
aiua-12856	81	44	≥	≥	PROPN
aiua-12856	81	45	1	1	NUM
aiua-12856	81	46	patients	patient	NOUN
aiua-12856	81	47	(	(	PUNCT
aiua-12856	81	48	63.6	63.6	NUM
aiua-12856	81	49	%	%	NOUN
aiua-12856	81	50	)	)	PUNCT
aiua-12856	81	51	having	have	VERB
aiua-12856	81	52	lymph	lymph	NOUN
aiua-12856	81	53	node	node	NOUN
aiua-12856	81	54	metastases	metastasis	NOUN
aiua-12856	81	55	when	when	SCONJ
aiua-12856	81	56	lymphadenectomy	lymphadenectomy	NOUN
aiua-12856	81	57	was	be	AUX
aiua-12856	81	58	performed	perform	VERB
aiua-12856	81	59	(	(	PUNCT
aiua-12856	81	60	p	p	X
aiua-12856	81	61	=	=	NOUN
aiua-12856	81	62	0.031	0.031	NUM
aiua-12856	81	63	)	)	PUNCT
aiua-12856	81	64	and	and	CCONJ
aiua-12856	81	65	only	only	ADV
aiua-12856	81	66	3	3	NUM
aiua-12856	81	67	out	out	ADP
aiua-12856	81	68	of	of	ADP
aiua-12856	81	69	12	12	NUM
aiua-12856	81	70	pd	pd	PROPN
aiua-12856	81	71	-	-	PROPN
aiua-12856	81	72	l1	l1	PROPN
aiua-12856	81	73	cps	cps	PROPN
aiua-12856	81	74	<	<	X
aiua-12856	81	75	1	1	NUM
aiua-12856	81	76	patients	patient	NOUN
aiua-12856	81	77	having	have	VERB
aiua-12856	81	78	lymph	lymph	NOUN
aiua-12856	81	79	node	node	ADJ
aiua-12856	81	80	involvement	involvement	NOUN
aiua-12856	81	81	.	.	PUNCT
aiua-12856	82	1	these	these	DET
aiua-12856	82	2	findings	finding	NOUN
aiua-12856	82	3	are	be	AUX
aiua-12856	82	4	in	in	ADP
aiua-12856	82	5	line	line	NOUN
aiua-12856	82	6	with	with	ADP
aiua-12856	82	7	those	those	PRON
aiua-12856	82	8	from	from	ADP
aiua-12856	82	9	udager	udager	NOUN
aiua-12856	82	10	and	and	CCONJ
aiua-12856	82	11	colleagues	colleague	NOUN
aiua-12856	82	12	that	that	PRON
aiua-12856	82	13	were	be	AUX
aiua-12856	82	14	among	among	ADP
aiua-12856	82	15	the	the	DET
aiua-12856	82	16	first	first	ADJ
aiua-12856	82	17	to	to	PART
aiua-12856	82	18	investigate	investigate	VERB
aiua-12856	82	19	pd	pd	PROPN
aiua-12856	82	20	-	-	ADJ
aiua-12856	82	21	l1	l1	PROPN
aiua-12856	82	22	expression	expression	NOUN
aiua-12856	82	23	in	in	ADP
aiua-12856	82	24	a	a	DET
aiua-12856	82	25	cohort	cohort	NOUN
aiua-12856	82	26	of	of	ADP
aiua-12856	82	27	37	37	NUM
aiua-12856	82	28	patients	patient	NOUN
aiua-12856	82	29	with	with	ADP
aiua-12856	82	30	penile	penile	ADJ
aiua-12856	82	31	sqcc	sqcc	NOUN
aiua-12856	82	32	.	.	PUNCT
aiua-12856	83	1	they	they	PRON
aiua-12856	83	2	discovered	discover	VERB
aiua-12856	83	3	that	that	SCONJ
aiua-12856	83	4	pd	pd	PROPN
aiua-12856	83	5	-	-	PUNCT
aiua-12856	83	6	l1	l1	PROPN
aiua-12856	83	7	expression	expression	NOUN
aiua-12856	83	8	was	be	AUX
aiua-12856	83	9	detected	detect	VERB
aiua-12856	83	10	in	in	ADP
aiua-12856	83	11	62.2	62.2	NUM
aiua-12856	83	12	%	%	NOUN
aiua-12856	83	13	of	of	ADP
aiua-12856	83	14	penile	penile	ADJ
aiua-12856	83	15	sqcc	sqcc	NOUN
aiua-12856	83	16	.	.	PUNCT
aiua-12856	84	1	despite	despite	SCONJ
aiua-12856	84	2	the	the	DET
aiua-12856	84	3	limited	limited	ADJ
aiua-12856	84	4	sample	sample	NOUN
aiua-12856	84	5	size	size	NOUN
aiua-12856	84	6	,	,	PUNCT
aiua-12856	84	7	they	they	PRON
aiua-12856	84	8	noted	note	VERB
aiua-12856	84	9	a	a	DET
aiua-12856	84	10	trend	trend	NOUN
aiua-12856	84	11	towards	towards	ADP
aiua-12856	84	12	worse	bad	ADJ
aiua-12856	84	13	clinical	clinical	ADJ
aiua-12856	84	14	clinicopathological	clinicopathological	ADJ
aiua-12856	84	15	features	feature	NOUN
aiua-12856	84	16	and	and	CCONJ
aiua-12856	84	17	worse	bad	ADJ
aiua-12856	84	18	overall	overall	ADJ
aiua-12856	84	19	survival	survival	NOUN
aiua-12856	84	20	but	but	CCONJ
aiua-12856	84	21	,	,	PUNCT
aiua-12856	84	22	at	at	ADP
aiua-12856	84	23	least	least	ADJ
aiua-12856	84	24	to	to	ADP
aiua-12856	84	25	our	our	PRON
aiua-12856	84	26	knowledge	knowledge	NOUN
aiua-12856	84	27	,	,	PUNCT
aiua-12856	84	28	no	no	DET
aiua-12856	84	29	statistically	statistically	ADV
aiua-12856	84	30	significant	significant	ADJ
aiua-12856	84	31	association	association	NOUN
aiua-12856	84	32	has	have	AUX
aiua-12856	84	33	been	be	AUX
aiua-12856	84	34	established	establish	VERB
aiua-12856	84	35	yet	yet	ADV
aiua-12856	84	36	(	(	PUNCT
aiua-12856	84	37	9	9	NUM
aiua-12856	84	38	)	)	PUNCT
aiua-12856	84	39	.	.	PUNCT
aiua-12856	85	1	this	this	DET
aiua-12856	85	2	finding	finding	NOUN
aiua-12856	85	3	suggests	suggest	VERB
aiua-12856	85	4	a	a	DET
aiua-12856	85	5	potential	potential	ADJ
aiua-12856	85	6	table	table	NOUN
aiua-12856	85	7	2	2	NUM
aiua-12856	85	8	.	.	PUNCT
aiua-12856	85	9	association	association	NOUN
aiua-12856	85	10	of	of	ADP
aiua-12856	85	11	pd	pd	PROPN
aiua-12856	85	12	-	-	PROPN
aiua-12856	85	13	l1	l1	PROPN
aiua-12856	85	14	expression	expression	NOUN
aiua-12856	85	15	with	with	ADP
aiua-12856	85	16	clinicopathological	clinicopathological	ADJ
aiua-12856	85	17	features	feature	NOUN
aiua-12856	85	18	.	.	PUNCT
aiua-12856	86	1	pd	pd	PROPN
aiua-12856	86	2	-	-	PROPN
aiua-12856	86	3	l1	l1	PROPN
aiua-12856	86	4	in	in	ADP
aiua-12856	86	5	tumor	tumor	NOUN
aiua-12856	86	6	cells	cell	NOUN
aiua-12856	86	7	,	,	PUNCT
aiua-12856	86	8	n	n	PROPN
aiua-12856	86	9	(	(	PUNCT
aiua-12856	86	10	%	%	INTJ
aiua-12856	86	11	)	)	PUNCT
aiua-12856	86	12	cps	cp	NOUN
aiua-12856	86	13	<	<	X
aiua-12856	86	14	1	1	NUM
aiua-12856	86	15	cps	cps	PROPN
aiua-12856	86	16	≥	≥	NOUN
aiua-12856	86	17	1	1	NUM
aiua-12856	86	18	tumor	tumor	NOUN
aiua-12856	86	19	size	size	NOUN
aiua-12856	86	20	(	(	PUNCT
aiua-12856	86	21	median	median	NOUN
aiua-12856	86	22	,	,	PUNCT
aiua-12856	86	23	cm	cm	NOUN
aiua-12856	86	24	)	)	PUNCT
aiua-12856	86	25	2.5	2.5	NUM
aiua-12856	86	26	(	(	PUNCT
aiua-12856	86	27	iqr	iqr	NOUN
aiua-12856	86	28	2.5	2.5	NUM
aiua-12856	86	29	)	)	PUNCT
aiua-12856	86	30	3.0	3.0	NUM
aiua-12856	86	31	(	(	PUNCT
aiua-12856	86	32	iqr	iqr	NOUN
aiua-12856	86	33	3.4	3.4	NUM
aiua-12856	86	34	)	)	PUNCT
aiua-12856	86	35	p	p	NOUN
aiua-12856	86	36	=	=	NOUN
aiua-12856	86	37	0.662	0.662	NUM
aiua-12856	86	38	p16	p16	NOUN
aiua-12856	86	39	immuno	immuno	ADJ
aiua-12856	86	40	-	-	PUNCT
aiua-12856	86	41	expression	expression	NOUN
aiua-12856	86	42	,	,	PUNCT
aiua-12856	86	43	n	n	CCONJ
aiua-12856	86	44	(	(	PUNCT
aiua-12856	86	45	%	%	INTJ
aiua-12856	86	46	)	)	PUNCT
aiua-12856	86	47	p	p	NOUN
aiua-12856	87	1	=	=	PUNCT
aiua-12856	87	2	0.252	0.252	NUM
aiua-12856	87	3	negative	negative	ADJ
aiua-12856	87	4	10	10	NUM
aiua-12856	87	5	(	(	PUNCT
aiua-12856	87	6	83.3	83.3	NUM
aiua-12856	87	7	%	%	NOUN
aiua-12856	87	8	)	)	PUNCT
aiua-12856	87	9	13	13	NUM
aiua-12856	87	10	(	(	PUNCT
aiua-12856	87	11	59.1	59.1	NUM
aiua-12856	87	12	%	%	NOUN
aiua-12856	87	13	)	)	PUNCT
aiua-12856	87	14	positive	positive	ADJ
aiua-12856	87	15	2	2	NUM
aiua-12856	87	16	(	(	PUNCT
aiua-12856	87	17	16.7	16.7	NUM
aiua-12856	87	18	%	%	NOUN
aiua-12856	87	19	)	)	PUNCT
aiua-12856	87	20	9	9	NUM
aiua-12856	87	21	(	(	PUNCT
aiua-12856	87	22	32.4	32.4	NUM
aiua-12856	87	23	%	%	NOUN
aiua-12856	87	24	)	)	PUNCT
aiua-12856	87	25	histological	histological	ADJ
aiua-12856	87	26	grade	grade	NOUN
aiua-12856	87	27	,	,	PUNCT
aiua-12856	87	28	n	n	CCONJ
aiua-12856	87	29	(	(	PUNCT
aiua-12856	87	30	%	%	INTJ
aiua-12856	87	31	)	)	PUNCT
aiua-12856	88	1	p	p	X
aiua-12856	88	2	=	=	NOUN
aiua-12856	88	3	0.360	0.360	NUM
aiua-12856	88	4	grade	grade	NOUN
aiua-12856	88	5	1	1	NUM
aiua-12856	88	6	5	5	NUM
aiua-12856	88	7	(	(	PUNCT
aiua-12856	88	8	41.7	41.7	NUM
aiua-12856	88	9	%	%	NOUN
aiua-12856	88	10	)	)	PUNCT
aiua-12856	88	11	6	6	NUM
aiua-12856	88	12	(	(	PUNCT
aiua-12856	88	13	27.3	27.3	NUM
aiua-12856	88	14	%	%	NOUN
aiua-12856	88	15	)	)	PUNCT
aiua-12856	88	16	grade	grade	NOUN
aiua-12856	88	17	2	2	NUM
aiua-12856	88	18	6	6	NUM
aiua-12856	88	19	(	(	PUNCT
aiua-12856	88	20	50.0	50.0	NUM
aiua-12856	88	21	%	%	NOUN
aiua-12856	88	22	)	)	PUNCT
aiua-12856	88	23	8	8	NUM
aiua-12856	88	24	(	(	PUNCT
aiua-12856	88	25	36.4	36.4	NUM
aiua-12856	88	26	%	%	NOUN
aiua-12856	88	27	)	)	PUNCT
aiua-12856	88	28	grade	grade	NOUN
aiua-12856	88	29	3	3	NUM
aiua-12856	88	30	1	1	NUM
aiua-12856	88	31	(	(	PUNCT
aiua-12856	88	32	8.3	8.3	NUM
aiua-12856	88	33	%	%	NOUN
aiua-12856	88	34	)	)	PUNCT
aiua-12856	88	35	7	7	NUM
aiua-12856	88	36	(	(	PUNCT
aiua-12856	88	37	31.8	31.8	NUM
aiua-12856	88	38	%	%	NOUN
aiua-12856	88	39	)	)	PUNCT
aiua-12856	88	40	grade	grade	NOUN
aiua-12856	88	41	4	4	NUM
aiua-12856	88	42	0	0	NUM
aiua-12856	88	43	(	(	PUNCT
aiua-12856	88	44	0.0	0.0	NUM
aiua-12856	88	45	%	%	NOUN
aiua-12856	88	46	)	)	PUNCT
aiua-12856	88	47	1	1	NUM
aiua-12856	88	48	(	(	PUNCT
aiua-12856	88	49	4.5	4.5	NUM
aiua-12856	88	50	%	%	NOUN
aiua-12856	88	51	)	)	PUNCT
aiua-12856	88	52	vascular	vascular	ADJ
aiua-12856	88	53	invasion	invasion	NOUN
aiua-12856	88	54	,	,	PUNCT
aiua-12856	88	55	n	n	CCONJ
aiua-12856	88	56	(	(	PUNCT
aiua-12856	88	57	%	%	INTJ
aiua-12856	88	58	)	)	PUNCT
aiua-12856	89	1	p	p	NOUN
aiua-12856	89	2	=	=	NOUN
aiua-12856	89	3	0.705	0.705	NUM
aiua-12856	89	4	no	no	DET
aiua-12856	89	5	9	9	NUM
aiua-12856	89	6	(	(	PUNCT
aiua-12856	89	7	75.0	75.0	NUM
aiua-12856	89	8	%	%	NOUN
aiua-12856	89	9	)	)	PUNCT
aiua-12856	89	10	14	14	NUM
aiua-12856	89	11	(	(	PUNCT
aiua-12856	89	12	63.6	63.6	NUM
aiua-12856	89	13	%	%	NOUN
aiua-12856	89	14	)	)	PUNCT
aiua-12856	90	1	yes	yes	INTJ
aiua-12856	90	2	3	3	NUM
aiua-12856	90	3	(	(	PUNCT
aiua-12856	90	4	25.0	25.0	NUM
aiua-12856	90	5	%	%	NOUN
aiua-12856	90	6	)	)	PUNCT
aiua-12856	90	7	8	8	NUM
aiua-12856	90	8	(	(	PUNCT
aiua-12856	90	9	36.4	36.4	NUM
aiua-12856	90	10	%	%	NOUN
aiua-12856	90	11	)	)	PUNCT
aiua-12856	91	1	perineural	perineural	ADJ
aiua-12856	91	2	invasion	invasion	NOUN
aiua-12856	91	3	,	,	PUNCT
aiua-12856	91	4	n	n	CCONJ
aiua-12856	91	5	(	(	PUNCT
aiua-12856	91	6	%	%	INTJ
aiua-12856	91	7	)	)	PUNCT
aiua-12856	92	1	p	p	NOUN
aiua-12856	92	2	=	=	PUNCT
aiua-12856	92	3	0.252	0.252	NUM
aiua-12856	92	4	no	no	DET
aiua-12856	92	5	10	10	NUM
aiua-12856	92	6	(	(	PUNCT
aiua-12856	92	7	83.3	83.3	NUM
aiua-12856	92	8	%	%	NOUN
aiua-12856	92	9	)	)	PUNCT
aiua-12856	92	10	13	13	NUM
aiua-12856	92	11	(	(	PUNCT
aiua-12856	92	12	59.1	59.1	NUM
aiua-12856	92	13	%	%	NOUN
aiua-12856	92	14	)	)	PUNCT
aiua-12856	93	1	yes	yes	INTJ
aiua-12856	93	2	2	2	NUM
aiua-12856	93	3	(	(	PUNCT
aiua-12856	93	4	16.7	16.7	NUM
aiua-12856	93	5	%	%	NOUN
aiua-12856	93	6	)	)	PUNCT
aiua-12856	93	7	9	9	NUM
aiua-12856	93	8	(	(	PUNCT
aiua-12856	93	9	40.9	40.9	NUM
aiua-12856	93	10	%	%	NOUN
aiua-12856	93	11	)	)	PUNCT
aiua-12856	94	1	pt	pt	NOUN
aiua-12856	94	2	stage	stage	NOUN
aiua-12856	94	3	,	,	PUNCT
aiua-12856	94	4	n	n	CCONJ
aiua-12856	94	5	(	(	PUNCT
aiua-12856	94	6	%	%	INTJ
aiua-12856	94	7	)	)	PUNCT
aiua-12856	95	1	p	p	NOUN
aiua-12856	96	1	=	=	PUNCT
aiua-12856	96	2	0.989	0.989	NUM
aiua-12856	96	3	pt1a	pt1a	ADJ
aiua-12856	96	4	3	3	NUM
aiua-12856	96	5	(	(	PUNCT
aiua-12856	96	6	25.0	25.0	NUM
aiua-12856	96	7	%	%	NOUN
aiua-12856	96	8	)	)	PUNCT
aiua-12856	96	9	6	6	NUM
aiua-12856	96	10	(	(	PUNCT
aiua-12856	96	11	27.3	27.3	NUM
aiua-12856	96	12	%	%	NOUN
aiua-12856	96	13	)	)	PUNCT
aiua-12856	96	14	pt2	pt2	NOUN
aiua-12856	96	15	4	4	NUM
aiua-12856	96	16	(	(	PUNCT
aiua-12856	96	17	33.3	33.3	NUM
aiua-12856	96	18	%	%	NOUN
aiua-12856	96	19	)	)	PUNCT
aiua-12856	96	20	7	7	NUM
aiua-12856	96	21	(	(	PUNCT
aiua-12856	96	22	31.8	31.8	NUM
aiua-12856	96	23	%	%	NOUN
aiua-12856	96	24	)	)	PUNCT
aiua-12856	96	25	pt3	pt3	NOUN
aiua-12856	96	26	5	5	NUM
aiua-12856	96	27	(	(	PUNCT
aiua-12856	96	28	41.7	41.7	NUM
aiua-12856	96	29	%	%	NOUN
aiua-12856	96	30	)	)	PUNCT
aiua-12856	96	31	9	9	NUM
aiua-12856	96	32	(	(	PUNCT
aiua-12856	96	33	40.9	40.9	NUM
aiua-12856	96	34	%	%	NOUN
aiua-12856	96	35	)	)	PUNCT
aiua-12856	96	36	lymph	lymph	NOUN
aiua-12856	96	37	node	node	NOUN
aiua-12856	96	38	involvement	involvement	NOUN
aiua-12856	96	39	,	,	PUNCT
aiua-12856	96	40	n	n	CCONJ
aiua-12856	96	41	(	(	PUNCT
aiua-12856	96	42	%	%	INTJ
aiua-12856	96	43	)	)	PUNCT
aiua-12856	97	1	p	p	NOUN
aiua-12856	97	2	=	=	PUNCT
aiua-12856	98	1	0.031	0.031	NUM
aiua-12856	98	2	no	no	DET
aiua-12856	98	3	9	9	NUM
aiua-12856	98	4	(	(	PUNCT
aiua-12856	98	5	75.0	75.0	NUM
aiua-12856	98	6	%	%	NOUN
aiua-12856	98	7	)	)	PUNCT
aiua-12856	98	8	8	8	NUM
aiua-12856	98	9	(	(	PUNCT
aiua-12856	98	10	50.0	50.0	NUM
aiua-12856	98	11	%	%	NOUN
aiua-12856	98	12	)	)	PUNCT
aiua-12856	99	1	yes	yes	INTJ
aiua-12856	99	2	3	3	NUM
aiua-12856	99	3	(	(	PUNCT
aiua-12856	99	4	25.0	25.0	NUM
aiua-12856	99	5	%	%	NOUN
aiua-12856	99	6	)	)	PUNCT
aiua-12856	99	7	14	14	NUM
aiua-12856	99	8	(	(	PUNCT
aiua-12856	99	9	63.6	63.6	NUM
aiua-12856	99	10	%	%	NOUN
aiua-12856	99	11	)	)	PUNCT
aiua-12856	99	12	figure	figure	NOUN
aiua-12856	99	13	1	1	NUM
aiua-12856	99	14	.	.	PUNCT
aiua-12856	100	1	overall	overall	ADJ
aiua-12856	100	2	survival	survival	NOUN
aiua-12856	100	3	stratified	stratify	VERB
aiua-12856	100	4	by	by	ADP
aiua-12856	100	5	pd	pd	PROPN
aiua-12856	100	6	-	-	PROPN
aiua-12856	100	7	l1	l1	PROPN
aiua-12856	100	8	status	status	NOUN
aiua-12856	100	9	.	.	PUNCT
aiua-12856	101	1	archivio	archivio	NOUN
aiua-12856	101	2	italiano	italiano	PROPN
aiua-12856	101	3	di	di	PROPN
aiua-12856	101	4	urologia	urologia	PROPN
aiua-12856	101	5	e	e	PROPN
aiua-12856	101	6	andrologia	andrologia	NOUN
aiua-12856	101	7	2024	2024	NUM
aiua-12856	101	8	;	;	PUNCT
aiua-12856	101	9	96(3):12856	96(3):12856	NUM
aiua-12856	101	10	i.	i.	NOUN
aiua-12856	101	11	peyroteo	peyroteo	PROPN
aiua-12856	101	12	,	,	PUNCT
aiua-12856	101	13	f.	f.	PROPN
aiua-12856	101	14	santos	santos	PROPN
aiua-12856	101	15	,	,	PUNCT
aiua-12856	101	16	c.	c.	PROPN
aiua-12856	101	17	marialva	marialva	PROPN
aiua-12856	101	18	,	,	PUNCT
aiua-12856	101	19	r.	r.	PROPN
aiua-12856	101	20	ramos	ramos	PROPN
aiua-12856	101	21	4	4	NUM
aiua-12856	101	22	role	role	NOUN
aiua-12856	101	23	for	for	ADP
aiua-12856	101	24	pd	pd	PROPN
aiua-12856	101	25	-	-	PUNCT
aiua-12856	101	26	l1	l1	PROPN
aiua-12856	101	27	expression	expression	NOUN
aiua-12856	101	28	in	in	ADP
aiua-12856	101	29	promoting	promote	VERB
aiua-12856	101	30	tumor	tumor	NOUN
aiua-12856	101	31	metastasis	metastasis	NOUN
aiua-12856	101	32	and	and	CCONJ
aiua-12856	101	33	aggressiveness	aggressiveness	NOUN
aiua-12856	101	34	.	.	PUNCT
aiua-12856	102	1	however	however	ADV
aiua-12856	102	2	,	,	PUNCT
aiua-12856	102	3	the	the	DET
aiua-12856	102	4	underlying	underlying	ADJ
aiua-12856	102	5	mechanisms	mechanism	NOUN
aiua-12856	102	6	driving	drive	VERB
aiua-12856	102	7	this	this	DET
aiua-12856	102	8	association	association	NOUN
aiua-12856	102	9	remain	remain	VERB
aiua-12856	102	10	unclear	unclear	ADJ
aiua-12856	102	11	and	and	CCONJ
aiua-12856	102	12	warrant	warrant	VERB
aiua-12856	102	13	further	further	ADJ
aiua-12856	102	14	investigation	investigation	NOUN
aiua-12856	102	15	through	through	ADP
aiua-12856	102	16	mechanistic	mechanistic	ADJ
aiua-12856	102	17	studies	study	NOUN
aiua-12856	102	18	.	.	PUNCT
aiua-12856	103	1	the	the	DET
aiua-12856	103	2	lack	lack	NOUN
aiua-12856	103	3	of	of	ADP
aiua-12856	103	4	a	a	DET
aiua-12856	103	5	standard	standard	ADJ
aiua-12856	103	6	second	second	ADJ
aiua-12856	103	7	-	-	PUNCT
aiua-12856	103	8	line	line	NOUN
aiua-12856	103	9	treatment	treatment	NOUN
aiua-12856	103	10	for	for	ADP
aiua-12856	103	11	patients	patient	NOUN
aiua-12856	103	12	with	with	ADP
aiua-12856	103	13	metastatic	metastatic	ADJ
aiua-12856	103	14	penile	penile	NOUN
aiua-12856	103	15	scc	scc	NOUN
aiua-12856	103	16	underscores	underscore	VERB
aiua-12856	103	17	the	the	DET
aiua-12856	103	18	urgent	urgent	ADJ
aiua-12856	103	19	need	need	NOUN
aiua-12856	103	20	for	for	ADP
aiua-12856	103	21	novel	novel	ADJ
aiua-12856	103	22	therapeutic	therapeutic	ADJ
aiua-12856	103	23	strategies	strategy	NOUN
aiua-12856	103	24	.	.	PUNCT
aiua-12856	104	1	the	the	DET
aiua-12856	104	2	emergence	emergence	NOUN
aiua-12856	104	3	of	of	ADP
aiua-12856	104	4	immune	immune	ADJ
aiua-12856	104	5	checkpoint	checkpoint	NOUN
aiua-12856	104	6	inhibitors	inhibitor	NOUN
aiua-12856	104	7	targeting	target	VERB
aiua-12856	104	8	the	the	DET
aiua-12856	104	9	pd-1	pd-1	NOUN
aiua-12856	104	10	/	/	SYM
aiua-12856	104	11	pd	pd	ADJ
aiua-12856	104	12	-	-	PUNCT
aiua-12856	104	13	l1	l1	PROPN
aiua-12856	104	14	pathway	pathway	NOUN
aiua-12856	104	15	has	have	AUX
aiua-12856	104	16	revolutionized	revolutionize	VERB
aiua-12856	104	17	cancer	cancer	NOUN
aiua-12856	104	18	treatment	treatment	NOUN
aiua-12856	104	19	across	across	ADP
aiua-12856	104	20	various	various	ADJ
aiua-12856	104	21	tumor	tumor	NOUN
aiua-12856	104	22	types	type	NOUN
aiua-12856	104	23	.	.	PUNCT
aiua-12856	105	1	our	our	PRON
aiua-12856	105	2	study	study	NOUN
aiua-12856	105	3	adds	add	VERB
aiua-12856	105	4	to	to	ADP
aiua-12856	105	5	the	the	DET
aiua-12856	105	6	growing	grow	VERB
aiua-12856	105	7	body	body	NOUN
aiua-12856	105	8	of	of	ADP
aiua-12856	105	9	evidence	evidence	NOUN
aiua-12856	105	10	supporting	support	VERB
aiua-12856	105	11	the	the	DET
aiua-12856	105	12	clinical	clinical	ADJ
aiua-12856	105	13	relevance	relevance	NOUN
aiua-12856	105	14	of	of	ADP
aiua-12856	105	15	pd	pd	PROPN
aiua-12856	105	16	-	-	PROPN
aiua-12856	105	17	l1	l1	PROPN
aiua-12856	105	18	expression	expression	NOUN
aiua-12856	105	19	as	as	ADP
aiua-12856	105	20	a	a	DET
aiua-12856	105	21	potential	potential	ADJ
aiua-12856	105	22	biomarker	biomarker	NOUN
aiua-12856	105	23	for	for	ADP
aiua-12856	105	24	immunotherapy	immunotherapy	NOUN
aiua-12856	105	25	response	response	NOUN
aiua-12856	105	26	in	in	ADP
aiua-12856	105	27	penile	penile	ADJ
aiua-12856	105	28	sqcc	sqcc	NOUN
aiua-12856	105	29	.	.	PUNCT
aiua-12856	106	1	in	in	ADP
aiua-12856	106	2	our	our	PRON
aiua-12856	106	3	study	study	NOUN
aiua-12856	106	4	,	,	PUNCT
aiua-12856	106	5	we	we	PRON
aiua-12856	106	6	observed	observe	VERB
aiua-12856	106	7	a	a	DET
aiua-12856	106	8	high	high	ADJ
aiua-12856	106	9	proportion	proportion	NOUN
aiua-12856	106	10	of	of	ADP
aiua-12856	106	11	patients	patient	NOUN
aiua-12856	106	12	with	with	ADP
aiua-12856	106	13	pd	pd	PROPN
aiua-12856	106	14	-	-	PROPN
aiua-12856	106	15	l1	l1	PROPN
aiua-12856	106	16	cps	cps	PROPN
aiua-12856	106	17	≥	≥	PROPN
aiua-12856	106	18	1	1	NUM
aiua-12856	106	19	(	(	PUNCT
aiua-12856	106	20	64,7	64,7	NUM
aiua-12856	106	21	%	%	NOUN
aiua-12856	106	22	)	)	PUNCT
aiua-12856	106	23	,	,	PUNCT
aiua-12856	106	24	which	which	PRON
aiua-12856	106	25	is	be	AUX
aiua-12856	106	26	in	in	ADP
aiua-12856	106	27	line	line	NOUN
aiua-12856	106	28	with	with	ADP
aiua-12856	106	29	the	the	DET
aiua-12856	106	30	current	current	ADJ
aiua-12856	106	31	literature	literature	NOUN
aiua-12856	106	32	(	(	PUNCT
aiua-12856	106	33	8	8	NUM
aiua-12856	106	34	,	,	PUNCT
aiua-12856	106	35	9	9	NUM
aiua-12856	106	36	)	)	PUNCT
aiua-12856	106	37	.	.	PUNCT
aiua-12856	107	1	until	until	ADP
aiua-12856	107	2	now	now	ADV
aiua-12856	107	3	,	,	PUNCT
aiua-12856	107	4	the	the	DET
aiua-12856	107	5	main	main	ADJ
aiua-12856	107	6	focus	focus	NOUN
aiua-12856	107	7	has	have	AUX
aiua-12856	107	8	been	be	AUX
aiua-12856	107	9	on	on	ADP
aiua-12856	107	10	hpv	hpv	ADJ
aiua-12856	107	11	related	relate	VERB
aiua-12856	107	12	penile	penile	ADJ
aiua-12856	107	13	carcinoma	carcinoma	NOUN
aiua-12856	107	14	that	that	SCONJ
aiua-12856	107	15	in	in	ADP
aiua-12856	107	16	our	our	PRON
aiua-12856	107	17	sample	sample	NOUN
aiua-12856	107	18	was	be	AUX
aiua-12856	107	19	only	only	ADV
aiua-12856	107	20	32,4	32,4	NUM
aiua-12856	107	21	%	%	NOUN
aiua-12856	107	22	,	,	PUNCT
aiua-12856	107	23	which	which	PRON
aiua-12856	107	24	is	be	AUX
aiua-12856	107	25	also	also	ADV
aiua-12856	107	26	in	in	ADP
aiua-12856	107	27	line	line	NOUN
aiua-12856	107	28	with	with	ADP
aiua-12856	107	29	the	the	DET
aiua-12856	107	30	current	current	ADJ
aiua-12856	107	31	evidence	evidence	NOUN
aiua-12856	107	32	(	(	PUNCT
aiua-12856	107	33	3	3	NUM
aiua-12856	107	34	)	)	PUNCT
aiua-12856	107	35	.	.	PUNCT
aiua-12856	108	1	given	give	VERB
aiua-12856	108	2	the	the	DET
aiua-12856	108	3	much	much	ADV
aiua-12856	108	4	higher	high	ADJ
aiua-12856	108	5	prevalence	prevalence	NOUN
aiua-12856	108	6	of	of	ADP
aiua-12856	108	7	pd	pd	PROPN
aiua-12856	108	8	-	-	PROPN
aiua-12856	108	9	l1	l1	PROPN
aiua-12856	108	10	expression	expression	NOUN
aiua-12856	108	11	there	there	PRON
aiua-12856	108	12	is	be	VERB
aiua-12856	108	13	potential	potential	ADJ
aiua-12856	108	14	for	for	ADP
aiua-12856	108	15	identifying	identify	VERB
aiua-12856	108	16	a	a	DET
aiua-12856	108	17	novel	novel	ADJ
aiua-12856	108	18	therapeutic	therapeutic	ADJ
aiua-12856	108	19	target	target	NOUN
aiua-12856	108	20	since	since	SCONJ
aiua-12856	108	21	the	the	DET
aiua-12856	108	22	literature	literature	NOUN
aiua-12856	108	23	indicates	indicate	VERB
aiua-12856	108	24	that	that	SCONJ
aiua-12856	108	25	tumors	tumor	NOUN
aiua-12856	108	26	expressing	express	VERB
aiua-12856	108	27	high	high	ADJ
aiua-12856	108	28	levels	level	NOUN
aiua-12856	108	29	of	of	ADP
aiua-12856	108	30	pd	pd	PROPN
aiua-12856	108	31	-	-	PROPN
aiua-12856	108	32	l1	l1	PROPN
aiua-12856	108	33	are	be	AUX
aiua-12856	108	34	more	more	ADV
aiua-12856	108	35	likely	likely	ADJ
aiua-12856	108	36	to	to	PART
aiua-12856	108	37	respond	respond	VERB
aiua-12856	108	38	to	to	ADP
aiua-12856	108	39	immunotherapy	immunotherapy	NOUN
aiua-12856	108	40	.	.	PUNCT
aiua-12856	109	1	additionally	additionally	ADV
aiua-12856	109	2	,	,	PUNCT
aiua-12856	109	3	in	in	ADP
aiua-12856	109	4	the	the	DET
aiua-12856	109	5	future	future	NOUN
aiua-12856	109	6	,	,	PUNCT
aiua-12856	109	7	it	it	PRON
aiua-12856	109	8	will	will	AUX
aiua-12856	109	9	be	be	AUX
aiua-12856	109	10	of	of	ADP
aiua-12856	109	11	interest	interest	NOUN
aiua-12856	109	12	to	to	PART
aiua-12856	109	13	observe	observe	VERB
aiua-12856	109	14	the	the	DET
aiua-12856	109	15	potential	potential	ADJ
aiua-12856	109	16	impact	impact	NOUN
aiua-12856	109	17	of	of	ADP
aiua-12856	109	18	male	male	ADJ
aiua-12856	109	19	hpv	hpv	ADJ
aiua-12856	109	20	vaccination	vaccination	NOUN
aiua-12856	109	21	on	on	ADP
aiua-12856	109	22	the	the	DET
aiua-12856	109	23	incidence	incidence	NOUN
aiua-12856	109	24	and	and	CCONJ
aiua-12856	109	25	oncological	oncological	ADJ
aiua-12856	109	26	outcomes	outcome	NOUN
aiua-12856	109	27	of	of	ADP
aiua-12856	109	28	penile	penile	ADJ
aiua-12856	109	29	cancer	cancer	NOUN
aiua-12856	109	30	.	.	PUNCT
aiua-12856	110	1	hpvrelated	hpvrelate	VERB
aiua-12856	110	2	penile	penile	NOUN
aiua-12856	110	3	cancers	cancer	NOUN
aiua-12856	110	4	are	be	AUX
aiua-12856	110	5	believed	believe	VERB
aiua-12856	110	6	to	to	PART
aiua-12856	110	7	have	have	VERB
aiua-12856	110	8	better	well	ADJ
aiua-12856	110	9	outcomes	outcome	NOUN
aiua-12856	110	10	(	(	PUNCT
aiua-12856	110	11	3	3	NUM
aiua-12856	110	12	)	)	PUNCT
aiua-12856	110	13	.	.	PUNCT
aiua-12856	111	1	if	if	SCONJ
aiua-12856	111	2	the	the	DET
aiua-12856	111	3	incidence	incidence	NOUN
aiua-12856	111	4	of	of	ADP
aiua-12856	111	5	hpv	hpv	NOUN
aiua-12856	111	6	-	-	PUNCT
aiua-12856	111	7	related	relate	VERB
aiua-12856	111	8	cancers	cancer	NOUN
aiua-12856	111	9	decreases	decrease	VERB
aiua-12856	111	10	as	as	ADP
aiua-12856	111	11	a	a	DET
aiua-12856	111	12	result	result	NOUN
aiua-12856	111	13	of	of	ADP
aiua-12856	111	14	vaccination	vaccination	NOUN
aiua-12856	111	15	efforts	effort	NOUN
aiua-12856	111	16	,	,	PUNCT
aiua-12856	111	17	we	we	PRON
aiua-12856	111	18	may	may	AUX
aiua-12856	111	19	encounter	encounter	VERB
aiua-12856	111	20	a	a	DET
aiua-12856	111	21	higher	high	ADJ
aiua-12856	111	22	proportion	proportion	NOUN
aiua-12856	111	23	of	of	ADP
aiua-12856	111	24	aggressive	aggressive	ADJ
aiua-12856	111	25	cases	case	NOUN
aiua-12856	111	26	.	.	PUNCT
aiua-12856	112	1	therefore	therefore	ADV
aiua-12856	112	2	,	,	PUNCT
aiua-12856	112	3	the	the	DET
aiua-12856	112	4	importance	importance	NOUN
aiua-12856	112	5	of	of	ADP
aiua-12856	112	6	novel	novel	ADJ
aiua-12856	112	7	strategies	strategy	NOUN
aiua-12856	112	8	will	will	AUX
aiua-12856	112	9	become	become	VERB
aiua-12856	112	10	even	even	ADV
aiua-12856	112	11	more	more	ADV
aiua-12856	112	12	significant	significant	ADJ
aiua-12856	112	13	.	.	PUNCT
aiua-12856	113	1	furthermore	furthermore	ADV
aiua-12856	113	2	,	,	PUNCT
aiua-12856	113	3	many	many	ADJ
aiua-12856	113	4	patients	patient	NOUN
aiua-12856	113	5	become	become	VERB
aiua-12856	113	6	ineligible	ineligible	ADJ
aiua-12856	113	7	for	for	ADP
aiua-12856	113	8	chemotherapy	chemotherapy	NOUN
aiua-12856	113	9	over	over	ADP
aiua-12856	113	10	time	time	NOUN
aiua-12856	113	11	,	,	PUNCT
aiua-12856	113	12	yet	yet	CCONJ
aiua-12856	113	13	they	they	PRON
aiua-12856	113	14	may	may	AUX
aiua-12856	113	15	still	still	ADV
aiua-12856	113	16	be	be	AUX
aiua-12856	113	17	suitable	suitable	ADJ
aiua-12856	113	18	candidates	candidate	NOUN
aiua-12856	113	19	for	for	ADP
aiua-12856	113	20	immunotherapy	immunotherapy	NOUN
aiua-12856	113	21	.	.	PUNCT
aiua-12856	114	1	offering	offer	VERB
aiua-12856	114	2	such	such	ADJ
aiua-12856	114	3	patients	patient	NOUN
aiua-12856	114	4	an	an	DET
aiua-12856	114	5	alternative	alternative	ADJ
aiua-12856	114	6	treatment	treatment	NOUN
aiua-12856	114	7	could	could	AUX
aiua-12856	114	8	prevent	prevent	VERB
aiua-12856	114	9	disease	disease	NOUN
aiua-12856	114	10	progression	progression	NOUN
aiua-12856	114	11	.	.	PUNCT
aiua-12856	115	1	if	if	SCONJ
aiua-12856	115	2	clinical	clinical	ADJ
aiua-12856	115	3	benefits	benefit	NOUN
aiua-12856	115	4	are	be	AUX
aiua-12856	115	5	demonstrated	demonstrate	VERB
aiua-12856	115	6	in	in	ADP
aiua-12856	115	7	this	this	DET
aiua-12856	115	8	advanced	advanced	ADJ
aiua-12856	115	9	setting	setting	NOUN
aiua-12856	115	10	,	,	PUNCT
aiua-12856	115	11	there	there	PRON
aiua-12856	115	12	is	be	VERB
aiua-12856	115	13	potential	potential	ADJ
aiua-12856	115	14	to	to	PART
aiua-12856	115	15	pursue	pursue	VERB
aiua-12856	115	16	approval	approval	NOUN
aiua-12856	115	17	for	for	ADP
aiua-12856	115	18	this	this	DET
aiua-12856	115	19	therapy	therapy	NOUN
aiua-12856	115	20	in	in	ADP
aiua-12856	115	21	earlier	early	ADJ
aiua-12856	115	22	stages	stage	NOUN
aiua-12856	115	23	as	as	ADP
aiua-12856	115	24	an	an	DET
aiua-12856	115	25	adjuvant	adjuvant	ADJ
aiua-12856	115	26	treatment	treatment	NOUN
aiua-12856	115	27	for	for	ADP
aiua-12856	115	28	tumors	tumor	NOUN
aiua-12856	115	29	with	with	ADP
aiua-12856	115	30	high	high	ADJ
aiua-12856	115	31	-	-	PUNCT
aiua-12856	115	32	risk	risk	NOUN
aiua-12856	115	33	features	feature	NOUN
aiua-12856	115	34	,	,	PUNCT
aiua-12856	115	35	similar	similar	ADJ
aiua-12856	115	36	to	to	ADP
aiua-12856	115	37	current	current	ADJ
aiua-12856	115	38	discussions	discussion	NOUN
aiua-12856	115	39	regarding	regard	VERB
aiua-12856	115	40	kidney	kidney	NOUN
aiua-12856	115	41	cancer	cancer	NOUN
aiua-12856	115	42	treatment	treatment	NOUN
aiua-12856	115	43	protocols	protocol	NOUN
aiua-12856	115	44	.	.	PUNCT
aiua-12856	116	1	despite	despite	SCONJ
aiua-12856	116	2	the	the	DET
aiua-12856	116	3	promising	promising	ADJ
aiua-12856	116	4	role	role	NOUN
aiua-12856	116	5	of	of	ADP
aiua-12856	116	6	pd	pd	PROPN
aiua-12856	116	7	-	-	PROPN
aiua-12856	116	8	l1	l1	PROPN
aiua-12856	116	9	expression	expression	NOUN
aiua-12856	116	10	as	as	ADP
aiua-12856	116	11	a	a	DET
aiua-12856	116	12	prognostic	prognostic	ADJ
aiua-12856	116	13	biomarker	biomarker	NOUN
aiua-12856	116	14	,	,	PUNCT
aiua-12856	116	15	our	our	PRON
aiua-12856	116	16	study	study	NOUN
aiua-12856	116	17	did	do	AUX
aiua-12856	116	18	not	not	PART
aiua-12856	116	19	find	find	VERB
aiua-12856	116	20	a	a	DET
aiua-12856	116	21	statistically	statistically	ADV
aiua-12856	116	22	significant	significant	ADJ
aiua-12856	116	23	association	association	NOUN
aiua-12856	116	24	between	between	ADP
aiua-12856	116	25	pd	pd	PROPN
aiua-12856	116	26	-	-	PROPN
aiua-12856	116	27	l1	l1	PROPN
aiua-12856	116	28	expression	expression	NOUN
aiua-12856	116	29	and	and	CCONJ
aiua-12856	116	30	overall	overall	ADJ
aiua-12856	116	31	survival	survival	NOUN
aiua-12856	116	32	.	.	PUNCT
aiua-12856	117	1	this	this	PRON
aiua-12856	117	2	may	may	AUX
aiua-12856	117	3	be	be	AUX
aiua-12856	117	4	attributed	attribute	VERB
aiua-12856	117	5	to	to	ADP
aiua-12856	117	6	the	the	DET
aiua-12856	117	7	relatively	relatively	ADV
aiua-12856	117	8	small	small	ADJ
aiua-12856	117	9	sample	sample	NOUN
aiua-12856	117	10	size	size	NOUN
aiua-12856	117	11	and	and	CCONJ
aiua-12856	117	12	short	short	ADJ
aiua-12856	117	13	follow	follow	NOUN
aiua-12856	117	14	-	-	PUNCT
aiua-12856	117	15	up	up	ADP
aiua-12856	117	16	duration	duration	NOUN
aiua-12856	117	17	.	.	PUNCT
aiua-12856	118	1	the	the	DET
aiua-12856	118	2	survival	survival	NOUN
aiua-12856	118	3	curves	curve	NOUN
aiua-12856	118	4	show	show	VERB
aiua-12856	118	5	a	a	DET
aiua-12856	118	6	trend	trend	NOUN
aiua-12856	118	7	towards	towards	ADP
aiua-12856	118	8	separation	separation	NOUN
aiua-12856	118	9	,	,	PUNCT
aiua-12856	118	10	suggesting	suggest	VERB
aiua-12856	118	11	that	that	SCONJ
aiua-12856	118	12	with	with	ADP
aiua-12856	118	13	a	a	DET
aiua-12856	118	14	larger	large	ADJ
aiua-12856	118	15	sample	sample	NOUN
aiua-12856	118	16	size	size	NOUN
aiua-12856	118	17	,	,	PUNCT
aiua-12856	118	18	the	the	DET
aiua-12856	118	19	survival	survival	NOUN
aiua-12856	118	20	outcomes	outcome	NOUN
aiua-12856	118	21	would	would	AUX
aiua-12856	118	22	likely	likely	ADV
aiua-12856	118	23	achieve	achieve	VERB
aiua-12856	118	24	statistical	statistical	ADJ
aiua-12856	118	25	significance	significance	NOUN
aiua-12856	118	26	.	.	PUNCT
aiua-12856	119	1	larger	large	ADJ
aiua-12856	119	2	studies	study	NOUN
aiua-12856	119	3	with	with	ADP
aiua-12856	119	4	longer	long	ADJ
aiua-12856	119	5	follow	follow	VERB
aiua-12856	119	6	-	-	PUNCT
aiua-12856	119	7	up	up	ADP
aiua-12856	119	8	periods	period	NOUN
aiua-12856	119	9	are	be	AUX
aiua-12856	119	10	warranted	warrant	VERB
aiua-12856	119	11	to	to	PART
aiua-12856	119	12	validate	validate	VERB
aiua-12856	119	13	our	our	PRON
aiua-12856	119	14	findings	finding	NOUN
aiua-12856	119	15	and	and	CCONJ
aiua-12856	119	16	assess	assess	VERB
aiua-12856	119	17	the	the	DET
aiua-12856	119	18	impact	impact	NOUN
aiua-12856	119	19	of	of	ADP
aiua-12856	119	20	pd	pd	PROPN
aiua-12856	119	21	-	-	PROPN
aiua-12856	119	22	l1	l1	PROPN
aiua-12856	119	23	expression	expression	NOUN
aiua-12856	119	24	on	on	ADP
aiua-12856	119	25	survival	survival	NOUN
aiua-12856	119	26	outcomes	outcome	NOUN
aiua-12856	119	27	in	in	ADP
aiua-12856	119	28	penile	penile	ADJ
aiua-12856	119	29	sqcc	sqcc	NOUN
aiua-12856	119	30	.	.	PUNCT
aiua-12856	120	1	several	several	ADJ
aiua-12856	120	2	limitations	limitation	NOUN
aiua-12856	120	3	should	should	AUX
aiua-12856	120	4	be	be	AUX
aiua-12856	120	5	considered	consider	VERB
aiua-12856	120	6	when	when	SCONJ
aiua-12856	120	7	interpreting	interpret	VERB
aiua-12856	120	8	our	our	PRON
aiua-12856	120	9	results	result	NOUN
aiua-12856	120	10	.	.	PUNCT
aiua-12856	121	1	first	first	ADV
aiua-12856	121	2	,	,	PUNCT
aiua-12856	121	3	our	our	PRON
aiua-12856	121	4	study	study	NOUN
aiua-12856	121	5	was	be	AUX
aiua-12856	121	6	retrospective	retrospective	ADJ
aiua-12856	121	7	and	and	CCONJ
aiua-12856	121	8	conducted	conduct	VERB
aiua-12856	121	9	at	at	ADP
aiua-12856	121	10	a	a	DET
aiua-12856	121	11	single	single	ADJ
aiua-12856	121	12	institution	institution	NOUN
aiua-12856	121	13	,	,	PUNCT
aiua-12856	121	14	which	which	PRON
aiua-12856	121	15	may	may	AUX
aiua-12856	121	16	introduce	introduce	VERB
aiua-12856	121	17	selection	selection	NOUN
aiua-12856	121	18	bias	bias	NOUN
aiua-12856	121	19	and	and	CCONJ
aiua-12856	121	20	limit	limit	VERB
aiua-12856	121	21	generalizability	generalizability	NOUN
aiua-12856	121	22	.	.	PUNCT
aiua-12856	122	1	second	second	ADJ
aiua-12856	122	2	,	,	PUNCT
aiua-12856	122	3	the	the	DET
aiua-12856	122	4	assessment	assessment	NOUN
aiua-12856	122	5	of	of	ADP
aiua-12856	122	6	pd	pd	PROPN
aiua-12856	122	7	-	-	PUNCT
aiua-12856	122	8	l1	l1	PROPN
aiua-12856	122	9	expression	expression	NOUN
aiua-12856	122	10	was	be	AUX
aiua-12856	122	11	based	base	VERB
aiua-12856	122	12	on	on	ADP
aiua-12856	122	13	immunohistochemistry	immunohistochemistry	NOUN
aiua-12856	122	14	,	,	PUNCT
aiua-12856	122	15	which	which	PRON
aiua-12856	122	16	has	have	VERB
aiua-12856	122	17	inherent	inherent	ADJ
aiua-12856	122	18	variability	variability	NOUN
aiua-12856	122	19	and	and	CCONJ
aiua-12856	122	20	subjectivity	subjectivity	NOUN
aiua-12856	122	21	.	.	PUNCT
aiua-12856	123	1	future	future	ADJ
aiua-12856	123	2	studies	study	NOUN
aiua-12856	123	3	incorporating	incorporate	VERB
aiua-12856	123	4	more	more	ADV
aiua-12856	123	5	robust	robust	ADJ
aiua-12856	123	6	techniques	technique	NOUN
aiua-12856	123	7	,	,	PUNCT
aiua-12856	123	8	such	such	ADJ
aiua-12856	123	9	as	as	ADP
aiua-12856	123	10	rna	rna	NOUN
aiua-12856	123	11	sequencing	sequencing	NOUN
aiua-12856	123	12	or	or	CCONJ
aiua-12856	123	13	multiplex	multiplex	NOUN
aiua-12856	123	14	immunofluorescence	immunofluorescence	NOUN
aiua-12856	123	15	,	,	PUNCT
aiua-12856	123	16	could	could	AUX
aiua-12856	123	17	provide	provide	VERB
aiua-12856	123	18	deeper	deep	ADJ
aiua-12856	123	19	insights	insight	NOUN
aiua-12856	123	20	into	into	ADP
aiua-12856	123	21	the	the	DET
aiua-12856	123	22	tumor	tumor	NOUN
aiua-12856	123	23	microenvironment	microenvironment	NOUN
aiua-12856	123	24	and	and	CCONJ
aiua-12856	123	25	immune	immune	ADJ
aiua-12856	123	26	landscape	landscape	NOUN
aiua-12856	123	27	in	in	ADP
aiua-12856	123	28	penile	penile	ADJ
aiua-12856	123	29	sqcc	sqcc	NOUN
aiua-12856	123	30	.	.	PUNCT
aiua-12856	124	1	despite	despite	SCONJ
aiua-12856	124	2	de	de	ADJ
aiua-12856	124	3	low	low	ADJ
aiua-12856	124	4	number	number	NOUN
aiua-12856	124	5	of	of	ADP
aiua-12856	124	6	cases	case	NOUN
aiua-12856	124	7	,	,	PUNCT
aiua-12856	124	8	reflecting	reflect	VERB
aiua-12856	124	9	the	the	DET
aiua-12856	124	10	rarity	rarity	NOUN
aiua-12856	124	11	of	of	ADP
aiua-12856	124	12	this	this	DET
aiua-12856	124	13	tumor	tumor	NOUN
aiua-12856	124	14	,	,	PUNCT
aiua-12856	124	15	our	our	PRON
aiua-12856	124	16	data	datum	NOUN
aiua-12856	124	17	comes	come	VERB
aiua-12856	124	18	from	from	ADP
aiua-12856	124	19	a	a	DET
aiua-12856	124	20	tertiary	tertiary	ADJ
aiua-12856	124	21	cancer	cancer	NOUN
aiua-12856	124	22	center	center	NOUN
aiua-12856	124	23	in	in	ADP
aiua-12856	124	24	portugal	portugal	PROPN
aiua-12856	124	25	,	,	PUNCT
aiua-12856	124	26	where	where	SCONJ
aiua-12856	124	27	all	all	DET
aiua-12856	124	28	decisions	decision	NOUN
aiua-12856	124	29	are	be	AUX
aiua-12856	124	30	based	base	VERB
aiua-12856	124	31	on	on	ADP
aiua-12856	124	32	multidisciplinary	multidisciplinary	ADJ
aiua-12856	124	33	tumor	tumor	NOUN
aiua-12856	124	34	boards	board	NOUN
aiua-12856	124	35	.	.	PUNCT
aiua-12856	125	1	besides	besides	SCONJ
aiua-12856	125	2	this	this	PRON
aiua-12856	125	3	,	,	PUNCT
aiua-12856	125	4	we	we	PRON
aiua-12856	125	5	exclusively	exclusively	ADV
aiua-12856	125	6	analysed	analyse	VERB
aiua-12856	125	7	conventional	conventional	ADJ
aiua-12856	125	8	squamous	squamous	ADJ
aiua-12856	125	9	cell	cell	NOUN
aiua-12856	125	10	carcinoma	carcinoma	NOUN
aiua-12856	125	11	and	and	CCONJ
aiua-12856	125	12	omitted	omit	VERB
aiua-12856	125	13	other	other	ADJ
aiua-12856	125	14	histologies	histology	NOUN
aiua-12856	125	15	to	to	PART
aiua-12856	125	16	avoid	avoid	VERB
aiua-12856	125	17	confounding	confound	VERB
aiua-12856	125	18	the	the	DET
aiua-12856	125	19	results	result	NOUN
aiua-12856	125	20	with	with	ADP
aiua-12856	125	21	histologies	histology	NOUN
aiua-12856	125	22	known	know	VERB
aiua-12856	125	23	to	to	PART
aiua-12856	125	24	have	have	VERB
aiua-12856	125	25	a	a	DET
aiua-12856	125	26	different	different	ADJ
aiua-12856	125	27	prognosis	prognosis	NOUN
aiua-12856	125	28	.	.	PUNCT
aiua-12856	126	1	conclusions	conclusion	NOUN
aiua-12856	126	2	our	our	PRON
aiua-12856	126	3	study	study	NOUN
aiua-12856	126	4	highlights	highlight	VERB
aiua-12856	126	5	the	the	DET
aiua-12856	126	6	association	association	NOUN
aiua-12856	126	7	between	between	ADP
aiua-12856	126	8	pd	pd	PROPN
aiua-12856	126	9	-	-	PROPN
aiua-12856	126	10	l1	l1	PROPN
aiua-12856	126	11	expression	expression	NOUN
aiua-12856	126	12	and	and	CCONJ
aiua-12856	126	13	worse	bad	ADJ
aiua-12856	126	14	clinical	clinical	ADJ
aiua-12856	126	15	outcomes	outcome	NOUN
aiua-12856	126	16	in	in	ADP
aiua-12856	126	17	penile	penile	ADJ
aiua-12856	126	18	sqcc	sqcc	NOUN
aiua-12856	126	19	.	.	PUNCT
aiua-12856	127	1	it	it	PRON
aiua-12856	127	2	is	be	AUX
aiua-12856	127	3	noteworthy	noteworthy	ADJ
aiua-12856	127	4	the	the	DET
aiua-12856	127	5	clinical	clinical	ADJ
aiua-12856	127	6	significance	significance	NOUN
aiua-12856	127	7	of	of	ADP
aiua-12856	127	8	lymph	lymph	NOUN
aiua-12856	127	9	node	node	NOUN
aiua-12856	127	10	involvement	involvement	NOUN
aiua-12856	127	11	in	in	ADP
aiua-12856	127	12	pd	pd	PROPN
aiua-12856	127	13	-	-	PROPN
aiua-12856	127	14	l1	l1	PROPN
aiua-12856	127	15	cps	cps	PROPN
aiua-12856	127	16	≥	≥	PROPN
aiua-12856	127	17	1	1	NUM
aiua-12856	127	18	cases	case	NOUN
aiua-12856	127	19	,	,	PUNCT
aiua-12856	127	20	suggesting	suggest	VERB
aiua-12856	127	21	a	a	DET
aiua-12856	127	22	potential	potential	ADJ
aiua-12856	127	23	role	role	NOUN
aiua-12856	127	24	of	of	ADP
aiua-12856	127	25	pdl1	pdl1	NOUN
aiua-12856	127	26	as	as	ADP
aiua-12856	127	27	a	a	DET
aiua-12856	127	28	predictive	predictive	ADJ
aiua-12856	127	29	biomarker	biomarker	NOUN
aiua-12856	127	30	for	for	ADP
aiua-12856	127	31	metastatic	metastatic	ADJ
aiua-12856	127	32	disease	disease	NOUN
aiua-12856	127	33	.	.	PUNCT
aiua-12856	128	1	references	reference	NOUN
aiua-12856	128	2	1	1	NUM
aiua-12856	128	3	.	.	PUNCT
aiua-12856	128	4	eau	eau	PROPN
aiua-12856	128	5	guidelines	guideline	NOUN
aiua-12856	128	6	(	(	PUNCT
aiua-12856	128	7	2024	2024	NUM
aiua-12856	128	8	)	)	PUNCT
aiua-12856	128	9	.	.	PUNCT
aiua-12856	129	1	edn	edn	PROPN
aiua-12856	129	2	.	.	PUNCT
aiua-12856	129	3	presented	present	VERB
aiua-12856	129	4	at	at	ADP
aiua-12856	129	5	the	the	DET
aiua-12856	129	6	eau	eau	PROPN
aiua-12856	129	7	annual	annual	ADJ
aiua-12856	129	8	congress	congress	PROPN
aiua-12856	129	9	paris	paris	PROPN
aiua-12856	129	10	2024	2024	NUM
aiua-12856	129	11	.	.	PUNCT
aiua-12856	130	1	2	2	NUM
aiua-12856	130	2	.	.	X
aiua-12856	130	3	bleeker	bleeker	PROPN
aiua-12856	130	4	mcg	mcg	PROPN
aiua-12856	130	5	,	,	PUNCT
aiua-12856	130	6	heideman	heideman	PROPN
aiua-12856	130	7	dam	dam	PROPN
aiua-12856	130	8	,	,	PUNCT
aiua-12856	130	9	snijders	snijder	NOUN
aiua-12856	130	10	pjf	pjf	PROPN
aiua-12856	130	11	,	,	PUNCT
aiua-12856	130	12	et	et	PROPN
aiua-12856	130	13	al	al	PROPN
aiua-12856	130	14	.	.	PROPN
aiua-12856	130	15	penile	penile	ADJ
aiua-12856	130	16	cancer	cancer	NOUN
aiua-12856	130	17	:	:	PUNCT
aiua-12856	130	18	epidemiology	epidemiology	NOUN
aiua-12856	130	19	,	,	PUNCT
aiua-12856	130	20	pathogenesis	pathogenesis	NOUN
aiua-12856	130	21	and	and	CCONJ
aiua-12856	130	22	prevention	prevention	NOUN
aiua-12856	130	23	.	.	PUNCT
aiua-12856	131	1	world	world	PROPN
aiua-12856	131	2	j	j	PROPN
aiua-12856	131	3	urol	urol	ADP
aiua-12856	131	4	2009	2009	NUM
aiua-12856	131	5	;	;	PUNCT
aiua-12856	131	6	27:141	27:141	NUM
aiua-12856	131	7	-	-	SYM
aiua-12856	131	8	150	150	NUM
aiua-12856	131	9	.	.	PUNCT
aiua-12856	132	1	3	3	X
aiua-12856	132	2	.	.	X
aiua-12856	133	1	backes	backes	PROPN
aiua-12856	133	2	dm	dm	PROPN
aiua-12856	133	3	,	,	PUNCT
aiua-12856	133	4	kurman	kurman	PROPN
aiua-12856	133	5	rj	rj	PROPN
aiua-12856	133	6	,	,	PUNCT
aiua-12856	133	7	pimenta	pimenta	PROPN
aiua-12856	133	8	jm	jm	PROPN
aiua-12856	133	9	,	,	PUNCT
aiua-12856	133	10	smith	smith	PROPN
aiua-12856	133	11	js	js	PROPN
aiua-12856	133	12	.	.	PUNCT
aiua-12856	134	1	systematic	systematic	ADJ
aiua-12856	134	2	review	review	NOUN
aiua-12856	134	3	of	of	ADP
aiua-12856	134	4	human	human	ADJ
aiua-12856	134	5	papillomavirus	papillomavirus	NOUN
aiua-12856	134	6	prevalence	prevalence	NOUN
aiua-12856	134	7	in	in	ADP
aiua-12856	134	8	invasive	invasive	ADJ
aiua-12856	134	9	penile	penile	ADJ
aiua-12856	134	10	cancer	cancer	NOUN
aiua-12856	134	11	.	.	PUNCT
aiua-12856	135	1	cancer	cancer	NOUN
aiua-12856	135	2	causes	cause	VERB
aiua-12856	135	3	control	control	NOUN
aiua-12856	135	4	2009	2009	NUM
aiua-12856	135	5	;	;	PUNCT
aiua-12856	135	6	20:449	20:449	NUM
aiua-12856	135	7	-	-	SYM
aiua-12856	135	8	457	457	NUM
aiua-12856	135	9	.	.	PUNCT
aiua-12856	136	1	4	4	NUM
aiua-12856	136	2	.	.	X
aiua-12856	136	3	brouwer	brouwer	PROPN
aiua-12856	136	4	or	or	CCONJ
aiua-12856	136	5	,	,	PUNCT
aiua-12856	136	6	rumble	rumble	ADJ
aiua-12856	136	7	rb	rb	NOUN
aiua-12856	136	8	,	,	PUNCT
aiua-12856	136	9	ayres	ayres	PROPN
aiua-12856	136	10	b	b	PROPN
aiua-12856	136	11	,	,	PUNCT
aiua-12856	136	12	et	et	PROPN
aiua-12856	137	1	al	al	PROPN
aiua-12856	137	2	.	.	PROPN
aiua-12856	137	3	penile	penile	ADJ
aiua-12856	137	4	cancer	cancer	NOUN
aiua-12856	137	5	:	:	PUNCT
aiua-12856	137	6	eauasco	eauasco	PROPN
aiua-12856	137	7	collaborative	collaborative	ADJ
aiua-12856	137	8	guidelines	guideline	NOUN
aiua-12856	137	9	update	update	VERB
aiua-12856	137	10	q	q	PUNCT
aiua-12856	137	11	and	and	CCONJ
aiua-12856	137	12	a.	a.	PROPN
aiua-12856	137	13	jco	jco	PROPN
aiua-12856	137	14	oncol	oncol	PROPN
aiua-12856	137	15	pract	pract	PROPN
aiua-12856	137	16	2024	2024	NUM
aiua-12856	137	17	;	;	PUNCT
aiua-12856	137	18	20:33	20:33	NUM
aiua-12856	137	19	-	-	SYM
aiua-12856	137	20	37	37	NUM
aiua-12856	137	21	.	.	PUNCT
aiua-12856	138	1	h	h	NOUN
aiua-12856	138	2	5	5	NUM
aiua-12856	138	3	.	.	PUNCT
aiua-12856	138	4	topalian	topalian	PROPN
aiua-12856	138	5	sl	sl	PROPN
aiua-12856	138	6	,	,	PUNCT
aiua-12856	138	7	hodi	hodi	PROPN
aiua-12856	138	8	fs	fs	PROPN
aiua-12856	138	9	,	,	PUNCT
aiua-12856	138	10	brahmer	brahmer	PROPN
aiua-12856	138	11	jr	jr	PROPN
aiua-12856	138	12	,	,	PUNCT
aiua-12856	138	13	et	et	PROPN
aiua-12856	138	14	al	al	PROPN
aiua-12856	138	15	.	.	PROPN
aiua-12856	138	16	safety	safety	PROPN
aiua-12856	138	17	,	,	PUNCT
aiua-12856	138	18	activity	activity	NOUN
aiua-12856	138	19	,	,	PUNCT
aiua-12856	138	20	and	and	CCONJ
aiua-12856	138	21	immune	immune	ADJ
aiua-12856	138	22	correlates	correlate	VERB
aiua-12856	138	23	of	of	ADP
aiua-12856	138	24	anti	anti	ADJ
aiua-12856	138	25	-	-	ADJ
aiua-12856	138	26	pd-1	pd-1	ADJ
aiua-12856	138	27	antibody	antibody	NOUN
aiua-12856	138	28	in	in	ADP
aiua-12856	138	29	cancer	cancer	NOUN
aiua-12856	138	30	.	.	PUNCT
aiua-12856	139	1	n	n	PROPN
aiua-12856	139	2	engl	engl	PROPN
aiua-12856	139	3	j	j	PROPN
aiua-12856	139	4	med	med	PROPN
aiua-12856	139	5	2012	2012	NUM
aiua-12856	139	6	;	;	PUNCT
aiua-12856	139	7	366:2443	366:2443	X
aiua-12856	139	8	-	-	SYM
aiua-12856	139	9	2454	2454	NUM
aiua-12856	139	10	.	.	PUNCT
aiua-12856	140	1	6	6	NUM
aiua-12856	140	2	.	.	X
aiua-12856	140	3	brahmer	brahmer	PROPN
aiua-12856	140	4	jr	jr	PROPN
aiua-12856	140	5	,	,	PUNCT
aiua-12856	140	6	tykodi	tykodi	PROPN
aiua-12856	140	7	ss	ss	PROPN
aiua-12856	140	8	,	,	PUNCT
aiua-12856	140	9	chow	chow	PROPN
aiua-12856	140	10	lqm	lqm	PROPN
aiua-12856	140	11	,	,	PUNCT
aiua-12856	140	12	et	et	PROPN
aiua-12856	140	13	al	al	PROPN
aiua-12856	140	14	.	.	PROPN
aiua-12856	140	15	safety	safety	NOUN
aiua-12856	140	16	and	and	CCONJ
aiua-12856	140	17	activity	activity	NOUN
aiua-12856	140	18	of	of	ADP
aiua-12856	140	19	anti	anti	ADJ
aiua-12856	140	20	-	-	ADJ
aiua-12856	140	21	pd	pd	ADJ
aiua-12856	140	22	-	-	PUNCT
aiua-12856	140	23	l1	l1	PROPN
aiua-12856	140	24	antibody	antibody	NOUN
aiua-12856	140	25	in	in	ADP
aiua-12856	140	26	patients	patient	NOUN
aiua-12856	140	27	with	with	ADP
aiua-12856	140	28	advanced	advanced	ADJ
aiua-12856	140	29	cancer	cancer	NOUN
aiua-12856	140	30	.	.	PUNCT
aiua-12856	141	1	n	n	PROPN
aiua-12856	141	2	engl	engl	PROPN
aiua-12856	141	3	j	j	PROPN
aiua-12856	141	4	med	med	PROPN
aiua-12856	141	5	2012	2012	NUM
aiua-12856	141	6	;	;	PUNCT
aiua-12856	141	7	366:2455	366:2455	NUM
aiua-12856	141	8	-	-	SYM
aiua-12856	141	9	2465	2465	NUM
aiua-12856	141	10	.	.	PUNCT
aiua-12856	142	1	7	7	X
aiua-12856	142	2	.	.	X
aiua-12856	142	3	el	el	NOUN
aiua-12856	142	4	-	-	NOUN
aiua-12856	142	5	mouallem	mouallem	PROPN
aiua-12856	142	6	n	n	CCONJ
aiua-12856	142	7	,	,	PUNCT
aiua-12856	142	8	paul	paul	PROPN
aiua-12856	142	9	ak	ak	PROPN
aiua-12856	142	10	.	.	PROPN
aiua-12856	142	11	immune	immune	ADJ
aiua-12856	142	12	checkpoint	checkpoint	NOUN
aiua-12856	142	13	inhibitors	inhibitor	NOUN
aiua-12856	142	14	for	for	ADP
aiua-12856	142	15	urothelial	urothelial	ADJ
aiua-12856	142	16	cancer	cancer	NOUN
aiua-12856	142	17	:	:	PUNCT
aiua-12856	142	18	an	an	DET
aiua-12856	142	19	update	update	NOUN
aiua-12856	142	20	on	on	ADP
aiua-12856	142	21	new	new	ADJ
aiua-12856	142	22	therapies	therapy	NOUN
aiua-12856	142	23	.	.	PUNCT
aiua-12856	143	1	fed	fed	PROPN
aiua-12856	143	2	pract	pract	PROPN
aiua-12856	143	3	2018	2018	NUM
aiua-12856	143	4	;	;	PUNCT
aiua-12856	143	5	35	35	NUM
aiua-12856	143	6	:	:	PUNCT
aiua-12856	143	7	s62	s62	NOUN
aiua-12856	143	8	.	.	PUNCT
aiua-12856	144	1	8	8	NUM
aiua-12856	144	2	.	.	X
aiua-12856	144	3	davidsson	davidsson	PROPN
aiua-12856	144	4	s	s	PROPN
aiua-12856	144	5	,	,	PUNCT
aiua-12856	144	6	carlsson	carlsson	PROPN
aiua-12856	144	7	j	j	PROPN
aiua-12856	144	8	,	,	PUNCT
aiua-12856	144	9	giunchi	giunchi	PROPN
aiua-12856	144	10	f	f	PROPN
aiua-12856	144	11	,	,	PUNCT
aiua-12856	144	12	et	et	PROPN
aiua-12856	144	13	al	al	PROPN
aiua-12856	144	14	.	.	PROPN
aiua-12856	144	15	pd	pd	PROPN
aiua-12856	144	16	-	-	PUNCT
aiua-12856	144	17	l1	l1	PROPN
aiua-12856	144	18	expression	expression	NOUN
aiua-12856	144	19	in	in	ADP
aiua-12856	144	20	men	man	NOUN
aiua-12856	144	21	with	with	ADP
aiua-12856	144	22	penile	penile	NOUN
aiua-12856	144	23	cancer	cancer	NOUN
aiua-12856	144	24	and	and	CCONJ
aiua-12856	144	25	its	its	PRON
aiua-12856	144	26	association	association	NOUN
aiua-12856	144	27	with	with	ADP
aiua-12856	144	28	clinical	clinical	ADJ
aiua-12856	144	29	outcomes	outcome	NOUN
aiua-12856	144	30	.	.	PUNCT
aiua-12856	145	1	eur	eur	PROPN
aiua-12856	145	2	urol	urol	ADJ
aiua-12856	145	3	oncol	oncol	PROPN
aiua-12856	145	4	2119	2119	NUM
aiua-12856	145	5	;	;	PUNCT
aiua-12856	145	6	2:214	2:214	NUM
aiua-12856	145	7	-	-	SYM
aiua-12856	145	8	221	221	NUM
aiua-12856	145	9	.	.	PUNCT
aiua-12856	146	1	9	9	X
aiua-12856	146	2	.	.	X
aiua-12856	146	3	u	u	NOUN
aiua-12856	146	4	udager	udager	NOUN
aiua-12856	146	5	am	be	AUX
aiua-12856	146	6	,	,	PUNCT
aiua-12856	146	7	liu	liu	PROPN
aiua-12856	146	8	ty	ty	PROPN
aiua-12856	146	9	,	,	PUNCT
aiua-12856	146	10	skala	skala	PROPN
aiua-12856	146	11	sl	sl	PROPN
aiua-12856	146	12	,	,	PUNCT
aiua-12856	146	13	et	et	PROPN
aiua-12856	146	14	al	al	PROPN
aiua-12856	146	15	.	.	PROPN
aiua-12856	147	1	frequent	frequent	PROPN
aiua-12856	147	2	pd	pd	PROPN
aiua-12856	147	3	-	-	PUNCT
aiua-12856	147	4	l1	l1	PROPN
aiua-12856	147	5	expression	expression	NOUN
aiua-12856	147	6	in	in	ADP
aiua-12856	147	7	primary	primary	ADJ
aiua-12856	147	8	and	and	CCONJ
aiua-12856	147	9	metastatic	metastatic	ADJ
aiua-12856	147	10	penile	penile	ADJ
aiua-12856	147	11	squamous	squamous	ADJ
aiua-12856	147	12	cell	cell	NOUN
aiua-12856	147	13	carcinoma	carcinoma	NOUN
aiua-12856	147	14	:	:	PUNCT
aiua-12856	147	15	potential	potential	ADJ
aiua-12856	147	16	opportunities	opportunity	NOUN
aiua-12856	147	17	for	for	ADP
aiua-12856	147	18	immunotherapeutic	immunotherapeutic	ADJ
aiua-12856	147	19	approaches	approach	NOUN
aiua-12856	147	20	.	.	PUNCT
aiua-12856	148	1	ann	ann	PROPN
aiua-12856	148	2	oncol	oncol	PROPN
aiua-12856	148	3	.	.	PUNCT
aiua-12856	149	1	2016	2016	NUM
aiua-12856	149	2	;	;	PUNCT
aiua-12856	149	3	27:1706	27:1706	NUM
aiua-12856	149	4	-	-	SYM
aiua-12856	149	5	12	12	NUM
aiua-12856	149	6	.	.	PUNCT
aiua-12856	150	1	10	10	NUM
aiua-12856	150	2	.	.	PUNCT
aiua-12856	150	3	bacco	bacco	PROPN
aiua-12856	150	4	mw	mw	X
aiua-12856	150	5	de	de	PROPN
aiua-12856	150	6	,	,	PUNCT
aiua-12856	150	7	carvalhal	carvalhal	NOUN
aiua-12856	150	8	gf	gf	PROPN
aiua-12856	150	9	,	,	PUNCT
aiua-12856	150	10	macgregor	macgregor	PROPN
aiua-12856	150	11	b	b	PROPN
aiua-12856	150	12	,	,	PUNCT
aiua-12856	150	13	et	et	PROPN
aiua-12856	150	14	al	al	PROPN
aiua-12856	150	15	.	.	PROPN
aiua-12856	150	16	pd	pd	PROPN
aiua-12856	150	17	-	-	PROPN
aiua-12856	150	18	l1	l1	PROPN
aiua-12856	150	19	and	and	CCONJ
aiua-12856	150	20	p16	p16	NOUN
aiua-12856	150	21	expression	expression	NOUN
aiua-12856	150	22	in	in	ADP
aiua-12856	150	23	penile	penile	ADJ
aiua-12856	150	24	squamous	squamous	ADJ
aiua-12856	150	25	cell	cell	NOUN
aiua-12856	150	26	carcinoma	carcinoma	NOUN
aiua-12856	150	27	from	from	ADP
aiua-12856	150	28	an	an	DET
aiua-12856	150	29	endemic	endemic	ADJ
aiua-12856	150	30	region	region	NOUN
aiua-12856	150	31	.	.	PUNCT
aiua-12856	151	1	clin	clin	PROPN
aiua-12856	151	2	genitourin	genitourin	PROPN
aiua-12856	151	3	cancer	cancer	NOUN
aiua-12856	151	4	2020	2020	NUM
aiua-12856	151	5	;	;	PUNCT
aiua-12856	151	6	18	18	NUM
aiua-12856	151	7	:	:	PUNCT
aiua-12856	151	8	e254	e254	PROPN
aiua-12856	151	9	-	-	PUNCT
aiua-12856	151	10	e259	e259	PROPN
aiua-12856	151	11	.	.	PUNCT
aiua-12856	152	1	correspondence	correspondence	NOUN
aiua-12856	152	2	inês	inês	NOUN
aiua-12856	152	3	peyroteo	peyroteo	NOUN
aiua-12856	152	4	(	(	PUNCT
aiua-12856	152	5	corresponding	correspond	VERB
aiua-12856	152	6	author	author	NOUN
aiua-12856	152	7	)	)	PUNCT
aiua-12856	152	8	ipeyroteo@gmail.com	ipeyroteo@gmail.com	PROPN
aiua-12856	153	1	celso	celso	PROPN
aiua-12856	153	2	marialva	marialva	PROPN
aiua-12856	153	3	rodrigo	rodrigo	PROPN
aiua-12856	153	4	ramos	ramos	PROPN
aiua-12856	153	5	portuguese	portuguese	PROPN
aiua-12856	153	6	institute	institute	PROPN
aiua-12856	153	7	of	of	ADP
aiua-12856	153	8	oncology	oncology	NOUN
aiua-12856	153	9	in	in	ADP
aiua-12856	153	10	lisbon	lisbon	PROPN
aiua-12856	153	11	,	,	PUNCT
aiua-12856	153	12	urology	urology	NOUN
aiua-12856	153	13	,	,	PUNCT
aiua-12856	153	14	lisbon	lisbon	PROPN
aiua-12856	153	15	,	,	PUNCT
aiua-12856	153	16	portugal	portugal	PROPN
aiua-12856	153	17	filipa	filipa	PROPN
aiua-12856	153	18	santos	santos	PROPN
aiua-12856	153	19	portuguese	portuguese	PROPN
aiua-12856	153	20	institute	institute	PROPN
aiua-12856	153	21	of	of	ADP
aiua-12856	153	22	oncology	oncology	NOUN
aiua-12856	153	23	in	in	ADP
aiua-12856	153	24	lisbon	lisbon	PROPN
aiua-12856	153	25	,	,	PUNCT
aiua-12856	153	26	pathology	pathology	NOUN
aiua-12856	153	27	,	,	PUNCT
aiua-12856	153	28	lisbon	lisbon	PROPN
aiua-12856	153	29	,	,	PUNCT
aiua-12856	153	30	portugal	portugal	PROPN
aiua-12856	153	31	conflict	conflict	NOUN
aiua-12856	153	32	of	of	ADP
aiua-12856	153	33	interest	interest	NOUN
aiua-12856	153	34	:	:	PUNCT
aiua-12856	153	35	the	the	DET
aiua-12856	153	36	authors	author	NOUN
aiua-12856	153	37	declare	declare	VERB
aiua-12856	153	38	no	no	DET
aiua-12856	153	39	potential	potential	ADJ
aiua-12856	153	40	conflict	conflict	NOUN
aiua-12856	153	41	of	of	ADP
aiua-12856	153	42	interest	interest	NOUN
aiua-12856	153	43	.	.	PUNCT
aiua-12856	154	1	this	this	DET
aiua-12856	154	2	work	work	NOUN
aiua-12856	154	3	was	be	AUX
aiua-12856	154	4	presented	present	VERB
aiua-12856	154	5	at	at	ADP
aiua-12856	154	6	american	american	PROPN
aiua-12856	154	7	association	association	PROPN
aiua-12856	154	8	of	of	ADP
aiua-12856	154	9	urology	urology	NOUN
aiua-12856	154	10	congress	congress	PROPN
aiua-12856	154	11	in	in	ADP
aiua-12856	154	12	2024	2024	NUM
aiua-12856	154	13	.	.	PUNCT